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Global summary of the AIDS epidemic 
December 2008
Number of people living with HIV in 2008   
 Total 33.4 million [31.1 million–35.8 million]  
 Adults 31.3 million [29.2 million–33.7 million]  
 Women 15.7 million [14.2 million–17.2 million]   
 Children under 15 years 2.1 million [1.2 million–2.9 million]  
People newly infected with HIV in 2008   
 Total 2.7 million [2.4 million–3.0 million] 
 Adults 2.3 million [2.0 million–2.5 million] 
 Children under 15 years 430 000 [240 000–610 000]
AIDS-related deaths in 2008  
 Total 2.0 million [1.7 million–2.4 million] 
 Adults 1.7 million [1.4 million–2.1 million] 
 Children under 15 years 280 000 [150 000–410 000]
The ranges around the estimates in this table define the boundaries within which the actual numbers lie, based on 
the best available information.
Introduction
The number of people living with HIV worldwide continued to grow in 2008, reaching an estimated 33.4 million 
[31.1 million–35.8 million]. The total number of people living with the virus in 2008 was more than 20% 
higher than the number in 2000, and the prevalence was roughly threefold higher than in 1990.
The continuing rise in the population of people 
living with HIV reflects the combined effects of 
continued high rates of new HIV infections and 
the beneficial impact of antiretroviral therapy. As of 
December 2008, approximately 4 million people in 
low- and middle-income countries were receiving 
antiretroviral therapy—a 10-fold increase over five 
years (World Health Organization, United Nations 
Children’s Fund, UNAIDS, 2009). In 2008, an 
estimated 2.7 million [2.4 million–3.0 million] 
Source: UNAIDS/WHO. 
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Global estimates 1990−2008
Estimate
High and low estimates
new HIV infections occurred. It is estimated that 
2 million [1.7 million–2.4 million] deaths due 
to AIDS-related illnesses occurred worldwide in 
2008.
The latest epidemiological data indicate that glob-
ally the spread of HIV appears to have peaked in 
1996, when 3.5 million [3.2 million–3.8 million] 
new HIV infections occurred. In 2008, the 
estimated number of new HIV infections was 
approximately 30% lower than at the epidemic’s 
peak 12 years earlier.Figure I
7
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Consistent with the long interval between HIV 
seroconversion and symptomatic disease, annual 
HIV-related mortality appears to have peaked in 
2004, when 2.2 million [1.9 million–2.6 million] 
deaths occurred. The estimated number of AIDS-
related deaths in 2008 is roughly 10% lower than 
in 2004.
An estimated 430 000 [240 000–610 000] new 
HIV infections occurred among children under 
the age of 15 in 2008. Most of these new 
infections are believed to stem from transmission 
in utero, during delivery or post-partum as a 
result of breastfeeding. The number of children 
newly infected with HIV in 2008 was roughly 
18% lower than in 2001.
This report summarizes the latest data on the 
epidemiology of HIV. The epidemiological 
estimates in this report reflect continued 
improvement in national HIV surveillance 
systems and estimation methodology (see the 
box ‘Deriving HIV estimates’). In 2007–2008, 
national household surveys with anonymous 
HIV testing components were conducted in 
11 countries, including nine in sub-Saharan 
Africa. Improvements in HIV surveillance and 
information systems not only provide a clearer, 
more reliable picture of the epidemic at the 
global, regional and country levels but are 
also helping national governments and other 
stakeholders to tailor AIDS responses in order to 
maximize the impact on public health.
The epidemic appears to have stabilized in most 
regions, although prevalence continues to increase 
in Eastern Europe and Central Asia and in other 
parts of Asia due to a high rate of new HIV 
infections. Sub-Saharan Africa remains the most 
heavily affected region, accounting for 71% of 
all new HIV infections in 2008. The resurgence 
of the epidemic among men who have sex with 
men in high-income countries is increasingly 
well-documented. Differences are apparent in all 
regions, with some national epidemics continuing 
to expand even as the overall regional HIV 
incidence stabilizes.
Key themes of the 2009 AIDS 
epidemic update
This report is divided into separate chapters that 
summarize epidemiological trends in individual 
regions. While regional differences remain, several 
themes are discernible:
 AIDS continues to be a major global health priority. 
Although important progress has been 
achieved in preventing new HIV infections 
and in lowering the annual number of AIDS-
related deaths, the number of people living 
with HIV continues to increase. AIDS-related 
illnesses remain one of the leading causes of 
death globally and are projected to continue as 
a significant global cause of premature 
mortality in the coming decades (World 
Health Organization, 2008). Although AIDS is 
no longer a new syndrome, global solidarity in 
the AIDS response will remain a necessity.
 There is geographic variation between and within 
countries and regions. Although this report 
focuses considerable attention on national 
trends, there are often large variations in HIV 
prevalence and epidemiological patterns within 
countries. The substantial diversity of national 
epidemics underscores not only the need to 
tailor prevention strategies to local needs but 
also the importance of decentralizing AIDS 
responses.
 The epidemic is evolving. Epidemic patterns can 
change over time. As the regional profiles in 
this report highlight, national epidemics 
throughout the world are experiencing impor-
tant transitions. In Eastern Europe and Central 
Asia, epidemics that were once characterized 
primarily by transmission among injecting 
drug users are now increasingly characterized 
by significant sexual transmission, while in 
parts of Asia epidemics are becoming increas-
ingly characterized by significant transmission 
among heterosexual couples.
 There is evidence of successes in HIV prevention. 
There is growing evidence of HIV prevention 
successes in diverse settings. In five countries 
where two recent national household surveys 
8
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were conducted, HIV incidence is on the 
decline, with the drop in new infections being 
statistically significant in two countries 
(Dominican Republic and United Republic of 
Tanzania) and statistically significant among 
women in a third (Zambia) (Hallett et al., in 
press). As previously discussed, the annual 
number of new HIV infections globally has 
declined, and HIV prevalence among young 
people has fallen in many countries (UNAIDS, 
2008). Globally, coverage for services to 
prevent mother-to-child HIV transmission rose 
from 10% in 2004 to 45% in 2008 (World 
Health Organization, United Nations 
Children’s Fund, UNAIDS, 2009), and the 
drop in new HIV infections among children in 
2008 suggests that these efforts are saving lives 
(see the box ‘The impact of antiretroviral 
prophylaxis to prevent mother-to-child trans-
mission of HIV’).
 Improved access to treatment is having an impact. 
Antiretroviral therapy coverage rose from 7% 
in 2003 to 42% in 2008, with especially high 
coverage achieved in eastern and southern 
Africa (48%) (World Health Organization, 
United Nations Children’s Fund, UNAIDS, 
2009). While the rapid expansion of access to 
antiretroviral therapy is helping to lower 
AIDS-related death rates in multiple countries 
and regions, it is also contributing to increases 
in HIV prevalence (see the box ‘Impact of 
increased access to treatment on epidemiolog-
ical trends’).
 There is increased evidence of risk among key 
populations. While high HIV prevalence has long 
been documented among sex workers in diverse 
countries worldwide, evidence was extremely 
limited regarding the contribution of men who 
have sex with men and injecting drug users to 
epidemics in sub-Saharan Africa and parts of 
Asia. In recent years, studies have documented 
elevated levels of infection in these populations 
in nearly all regions. In all settings and for 
diverse types of epidemics, it is clear that 
programmes to prevent new infections among 
these key populations must constitute an 
important part of national AIDS responses.
What do the most recent data  
tell us?
UNAIDS recommends that countries ground 
their AIDS strategies in an understanding of their 
individual epidemics and their national responses. 
The data presented in this report indicate that 
this is often failing to occur. The failure to match 
national AIDS strategies to documented national 
needs has been vividly illustrated by recent modes 
of transmission studies and HIV prevention 
syntheses conducted in a number of countries.
The common failure to prioritize focused HIV 
prevention programmes for key populations is 
especially apparent. Even though injecting drug 
users, men who have sex with men, sex workers, 
prisoners and mobile workers are at higher risk 
of HIV infection, the level of resources directed 
towards focused prevention programmes for these 
groups is typically quite low, even in concentrated 
epidemics (UNAIDS, 2008).
Gaps are also evident in basic prevention 
approaches in hyperendemic settings. As the 
chapter on sub-Saharan Africa explains, even 
though the largest share of new infections in 
many African countries occurs among older 
heterosexual couples, relatively few prevention 
programmes have specifically focused on older 
adults. Although serodiscordant couples account 
for a substantial percentage of new infections in 
some African countries, HIV testing and counsel-
ling programmes are seldom geared specifically for 
serodiscordant couples. Many programmes focused 
on young people fail to address some of the key 
determinants of vulnerability, such as the high 
prevalence of intergenerational partnerships in 
many countries. 
Another important programmatic gap evident in 
recent HIV prevention syntheses is the typical 
shortage of programmes specifically designed 
for people living with HIV. UNAIDS recom-
mends that urgent efforts to involve people living 
with HIV in the planning, implementation and 
monitoring of prevention efforts be grounded 
in human rights principles and be supported by 
strong legal protection.
9
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Advancing the UNAIDS Outcome 
Framework 2009–2011
In 2009, the UNAIDS Secretariat and Cosponsors 
proposed—and the UNAIDS Programme 
Coordinating Board endorsed—a set of specific 
outcomes that the Joint Programme will aim to 
catalyse support for in 2009–2011 (UNAIDS, 
2009). While continuing to work towards compre-
hensive national responses to AIDS throughout the 
world, the outcome framework sets out a limited 
number of specific aims to guide future invest-
ments and to mobilize focused, concerted action.
The evidence summarized in this report under-
scores both the urgency of the priority outcomes 
identified in the new UNAIDS framework and the 
feasibility of achieving concrete progress in specific 
areas. As the recent declines in HIV incidence in 
multiple countries demonstrate, it is possible to 
reduce sexual transmission of HIV. Likewise, the 
increasing coverage of services to prevent mother-
UNAIDS Outcome Framework 2009–2011: nine priority areas
 We can reduce sexual transmission of HIV.
 We can prevent mothers from dying and babies from becoming infected with HIV.
 We can ensure that people living with HIV receive treatment.
 We can prevent people living with HIV from dying of tuberculosis.
 We can protect drug users from becoming infected with HIV.
 We can remove punitive laws, policies, practices, stigma and discrimination that 
block effective responses to AIDS. 
 We can stop violence against women and girls.
 We can empower young people to protect themselves from HIV.
 We can enhance social protection for people affected by HIV.
to-child transmission and the associated declines 
in new HIV infections among children highlight 
the feasibility of preventing mothers from dying 
and babies from becoming infected with HIV. The 
growing body of evidence regarding the salutary 
health effects of increased access to treatment 
underscores the importance of ensuring that all 
people living with HIV receive the treatment they 
need.
As this report describes, however, progress is 
not universally evident across the broad range 
of outcomes in the 2009–2011 framework, and 
where progress has been made it has sometimes 
been only partial or episodic. The data summarized 
in the subsequent regional profiles highlight areas 
where more intensified action is needed in order 
to achieve the desired impact across the breadth of 
the AIDS response. 
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Adults and children
living with HIV
Adults and children
newly infected with HIV
Adult prevalence
(%)
Adult and child deaths
due to AIDS
22.4 million 
[20.8 million–24.1 million]
1.9 million 
[1.6 million–2.2 million]
5.2
 [4.9–5.4]
1.4 million
[1.1 million–1.7 million]
19.7 million
[18.3 million–21.2 million]
2.3 million
[2.0 million–2.5 million]
5.8
 [5.5–6.0]
1.4 million
[1.2 million–1.7 million]
310 000 
[250 000–380 000]
35 000
[24 000–46 000]
0.2
 [<0.2–0.3]
20 000
[15 000–25 000]
200 000
[150 000–250 000]
30 000
[23 000–40 000]
0.2
 [0.1–0.2]
11 000
[7800–14 000]
3.8 million
[3.4 million–4.3 million]
280 000 
[240 000–320 000]
0.3
 [0.2–0.3]
270 000
[220 000–310 000]
4.0 million
[3.5 million–4.5 million]
310 000 
[270 000–350 000]
0.3
 [<0.3–0.4]
260 000
[210 000–320 000]
850 000
[700 000–1.0 million]
75 000
[58 000–88 000]
<0.1
 [<0.1]
59 000
[46 000–71 000]
560 000
[480 000–650 000]
99 000
[75 000–120 000]
<0.1
 [<0.1]
22 000
[18 000–27 000]
59 000
[51 000–68 000]
3900
[2900–5100]
0.3
 [<0.3–0.4]
2000
[1100–3100]
36 000
[29 000–45 000]
5900
[4800–7300]
0.2
 [<0.2–0.3]
<1000
[<500–1200]
2.0 million
[1.8 million–2.2 million]
170 000
[150 000–200 000]
0.6
 [0.5–0.6]
77 000
[66 000–89 000]
1.6 million
[1.5 million–1.8 million]
150 000
[140 000–170 000]
0.5
 [<0.5–0.6]
66 000
[56 000–77 000]
240 000
[220 000–260 000]
20 000
[16 000–24 000]
1.0
 [0.9–1.1]
12 000
[9300–14 000]
220 000
[200 000–240 000]
21 000
[17 000–24 000]
1.1
 [1.0–1.2]
20 000
[17 000–23 000]
1.5 million
[1.4 million–1.7 million]
110 000
[100 000–130 000]
0.7
 [0.6–0.8]
87 000
[72 000–110 000]
900 000
[800 000–1.1 million]
280 000
[240 000–320 000]
0.5
 [0.4–0.5]
26 000
[22 000–30 000]
850 000
[710 000–970 000]
30 000
[23 000–35 000]
0.3
[0.2–0.3]
13 000
[10 000–15 000]
660 000
[580 000–760 000]
40 000
[31 000–47 000]
7900
[6500–9700]
1.4 million
[1.2 million–1.6 million]
55 000 
[36 000–61 000]
0.4
[0.3–0.5]
25 000
[20 000–31 000]
1.2 million
[1.1 million–1.4 million]
52 000
[42 000–60 000]
0.4
 [<0.4–0.5]
19 000
[16 000–23 000]
33.4 million
[31.1 million–35.8 million]
2.7 million
[2.4 million–3.0 million]
0.8
 [<0.8–0.8]
2.0 million
[1.7 million–2.4 million]
29.0 million
[27.0 million–31.0 million]
3.2 million
[2.9 million–3.6 million]
0.8
 [<0.8–0.8]
1.9 million
[1.6 million–2.2 million]
2008
2001
2008
Sub-Saharan Africa
Middle East and North Africa
South and South-East Asia
East Asia
2008
2001
2008
2001
2001
2008
2001
2008
Oceania
Latin America
2001
2008
2001
2008
Eastern Europe and Central Asia
Caribbean
2001
2008
2001
Western and Central Europe
North America
TOTAL
2001
2008
2001
2008
0.3
[0.2–0.3]
Regional HIV and AIDS statistics, 2001 and 2008
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Advances in characterizing HIV incidence
Knowing their epidemic and their response can help countries to craft an optimally effective 
national response (UNAIDS, 2007). A long-standing impediment to putting this advice into 
practice has been the difficulty of reliably estimating and characterizing new HIV infections. In 
the absence of a clear understanding of the rate of new infections and of the population and 
geographic distribution of incident infections, it has proven challenging for national authorities 
to maximize the impact of HIV prevention strategies.
The gold standard for the direct measurement of incidence is the cohort study, in which 
HIV-uninfected people are followed over time. However, due to the enormous costs, time 
requirements and complexities associated with cohort studies, these tend to be conducted 
in specific settings and not for national populations. In addition, cohort studies are subject to 
biases associated with recruitment and loss to follow-up.  
In recent years, notable advances have been made in other approaches for gauging new HIV 
infections. These include indirect mathematical or statistical methods to estimate incidence 
and laboratory tests that help to measure directly the rate of new infections. Collectively, these 
methods are providing national planners with a more accurate and more timely understanding 
of the dynamics of national epidemics.
Indirectly estimating HIV incidence
Indirect strategies for estimating HIV incidence include the combination of the Estimating 
and Projection Package (EPP) and Spectrum mathematical modelling software tools that 
120 countries worldwide have used to generate the epidemiological estimates reported 
annually by UNAIDS. EPP/Spectrum combines available HIV surveillance data with data from 
programmes for antiretroviral therapy and prevention of mother-to-child HIV transmission 
to calculate HIV prevalence, HIV incidence, AIDS mortality, number of AIDS orphans and 
HIV treatment needs. In 2009, alterations were introduced to EPP and Spectrum to improve 
the model’s ability to estimate HIV incidence (see www.unaids.org for the software, model 
description and user manual). Trends in incidence obtained by this method feature in the 
regional summaries of this report.
Another mathematical model developed by Hallett et al. uses successive rounds of national 
cross-sectional HIV prevalence data to estimate HIV incidence by age in the general 
population (Hallett et al., 2008). Still other dynamic models have been developed to generate 
HIV incidence estimates (Williams et al., 2001; Gregson et al., 1996). 
Trends in HIV prevalence among young people are less subject to changes over time due 
to mortality and the effect of antiretroviral therapy than are the trends in prevalence among 
people of all ages. Therefore, trends in prevalence among antenatal clinic attendees aged 15–
24 years old have been used to assess trends in incidence in countries with a high prevalence 
(UNAIDS, 2008). Similarly, differences in age-specific prevalence in national surveys have been 
used to assess trends in incidence (Shisana et al., 2009).
The ‘incidence by modes of transmission’ approach, developed by the UNAIDS Reference 
Group on Estimates, Modelling and Projections, estimates the number of new infections in a 
given year. Unlike the previously described methods, the modes of transmission analysis does 
not aim to identify incidence trends over time. The model assumes that the risk of infection 
for any individual is a function of the HIV prevalence among partners, the number of partners 
and the number of contacts with each partner, with additional weight given to the presence 
or absence of sexually transmitted infections and to circumcision status. The model allows for 
estimates of new infections to be developed by population and transmission source.
The ‘incidence modes of transmission’ model is already proving useful in detecting dissonance 
between national prevention programmes and epidemiological patterns. With the support of 
UNAIDS, 12 countries have undertaken modes of transmission analyses in the past two years. 
12
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These exercises identified critical epidemiological trends in different countries, such as the 
prominence of new infections among ‘low-risk’ heterosexual couples in Uganda or the notable 
number of new infections occurring among vulnerable populations in Kenya. Countries are now 
using this analysis of epidemiological dynamics to refine their surveillance approaches and to 
reformulate national prevention strategies to respond in a timely way to emerging trends.  
Laboratory assay-based measures of HIV incidence
Several assays and techniques have been developed to distinguish recent infections from long-
standing infections. When applied to blood specimens collected from testing facilities, these 
tests can help to identify the rate at which new HIV infections are occurring. 
Most of the laboratory incidence measures are in the serologic testing algorithm for recent HIV 
seroconversion, or STARHS, category. STARHS tests detect various properties associated with 
early HIV-1 antibodies following seroconversion. In 2008, the US Centers for Disease Control 
and Prevention (CDC) used a STARHS-like assay to produce the first-ever direct estimate of 
annual HIV incidence in the USA (Hall et al., 2008). The approach used by CDC to develop 
its incidence estimate depends on the existence of additional clinical and epidemiological 
information on individuals (including antiretroviral status and CD4 count) and on the modelling 
of testing behaviour. The national epidemiological picture developed by CDC included 
the first-ever estimates of incident infections by race/ethnicity, age, gender and mode of 
transmission. In recent years, epidemiologists have applied various laboratory tests to estimate 
HIV incidence in testing facility settings (Schüpbach et al., 2007; Suligoi et al., 2007).
Although these strategies are an important sign of progress, their application in survey 
settings in low- and middle-income countries has identified several challenges. In particular, 
they misclassified some individuals who had been infected for a long time and some people 
who were on antiretroviral therapy as recently infected (see Hargrove et al., 2008). Further 
development of new assays and of assay algorithms are needed, as well as an extensive 
validation in field settings, before these approaches can be confidently applied. 
More information can be found at http://www.who.int/diagnostics_laboratory/links/hiv_
incidence_assay/en/index1.html.
The impact of antiretroviral prophylaxis to prevent mother-to-child 
transmission of HIV
Effective prevention of mother-to-child transmission involves simultaneous support for several strat-
egies that work synergistically to reduce the odds that an infant will become infected as a result of 
exposure to the mother’s virus. Through the reduction in overall HIV among reproductive-age wom-
en and men, the reduction of unwanted pregnancies among HIV-positive women, the provision of 
antiretroviral drugs to reduce the chance of infection during pregnancy and delivery and appropri-
ate treatment, care and support to mothers living with HIV (including infant feeding), programmes 
are able to reduce the chance that infants will become infected. In ideal conditions, the provision of 
antiretroviral prophylaxis and replacement feeding can reduce transmission from an estimated 30% 
to 35% with no intervention to around 1% to 2%. Most countries have not yet reached all pregnant 
women with these services, let alone significantly reduced HIV prevalence among reproductive-age 
individuals or unwanted pregnancies among HIV-positive women.
It is challenging to measure the impact of the full range of services to prevent mother-to-child HIV 
transmission. Exclusively examining the provision of antiretroviral drugs for prophylaxis to HIV-
positive pregnant women, UNAIDS estimates that 200 000 cumulative new HIV infections have 
been averted in the past 12 years (Figures II and III). This represents only a fraction of the overall 
infections among infants averted through prevention interventions, as the analysis focuses solely 
on a single prong of the broader package of services to prevent mother-to-child transmission. 
13
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Figure II
Estimate of the annual number of infant infections averted through the provision of 
antiretroviral prophylaxis to HIV-positive pregnant women, globally, 1996–2008
At current levels of antiretroviral prophylaxis
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Figure III
Estimated number of new child infections at current levels of antiretroviral prophylaxis and 
without antiretroviral prophylaxis, globally, 1996–2008
Regional estimates of the number of infant infections at current levels of antiretroviral 
prophylaxis and without antiretroviral prophylaxis are shown in Figure IV. The cumulative 
estimated numbers of infections averted in each region were: 134 000 in sub-Saharan 
Africa, 33 000 in Asia, 23 000 in Western Europe and North America (figure not shown), 
7000 in South and Central America, 7000 in East Europe and Central Asia and 1000 in the 
Caribbean. The cumulative number of infections averted in Oceania (figure not shown) and 
the Middle East and North Africa were both less than 100.
14
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Figure IV
Regional estimates of the number of infant infections at current levels of antiretroviral prophylaxis 
and without antiretroviral prophylaxis
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Impact of increased access to treatment on epidemiological trends
There has been an unprecedented increase in access to HIV treatment this decade in resource-limited 
settings where antiretroviral medications were previously unavailable. Between 2003 and 2008, access 
to antiretroviral drugs in low- and middle-income countries rose 10-fold (World Health Organization, 
United Nations Children’s Fund, UNAIDS, 2009).
In high-income countries where antiretroviral drugs have long been widely available, access to 
treatment has had an extraordinary impact on HIV-related mortality. In a multicentre study in 12 high-
income countries, the rate of excess mortality among people living with HIV in comparison with the HIV-
uninfected population declined by 85% following the introduction of highly-active antiretroviral therapy 
(Bhaskaran et al., 2008). The pronounced declines in AIDS-related deaths as a result of advances in 
treatment have contributed to an increase in HIV prevalence in high-income countries (Centers for 
Disease Control and Prevention, 2008).
As the number of people receiving antiretroviral drugs in resource-limited settings has increased, evi-
dence has emerged to confirm comparable improvements in longevity among people living with HIV in 
low- and middle-income countries. In Brazil, where free antiretroviral therapy has been available since 
1996, average survival following an AIDS diagnosis in São Paulo state rose from four months in 1992–
1995 to 50 months in 1998–2001 (Kilsztajn et al., 2007). In a prospective cohort study in Uganda, a 
combination of antiretroviral drugs and co-trimoxazole reduced mortality by 95% in comparison with no 
intervention (Mermin et al., 2008). An estimated 79% of adults enrolled in the early stages of Botswana’s 
antiretroviral therapy scale-up were alive five years later (Bussmann et al., 2008). With the largest antiret-
roviral therapy programme in the world, South Africa is experiencing substantial public health benefits 
associated with improved treatment access. In the Western Cape Province of South Africa, six-month 
mortality among patients at an HIV treatment centre fell by roughly half (from 12.7% to 6.6%) between 
the start of the antiretroviral therapy programme in 2001/2002 and 2005 as more patients with less 
severe immunosuppression enrolled (Boulle et al., 2008). 
Although current estimates of coverage of antiretroviral therapy for children are close to those of adults 
(World Health Organization, United Nations Children’s Fund, UNAIDS, 2009), the provision of antiret-
roviral therapy to children has specific challenges, including the faster progression to AIDS and death, 
the difficulty of diagnosing HIV in children and the challenges in developing affordable and appropriate 
antiretroviral regimens for children (UNAIDS, 2008). Advances in several components of HIV treatment 
for children are now being reflected in epidemiological data. Use of simplified assays on dried blood 
spots now offers a feasible, cost-effective means of diagnosing HIV in infants and young children (Ou et 
al., 2007). Early diagnosis and early antiretroviral therapy were found to reduce infant mortality by 76% 
and to slow HIV-related disease progression by 75% in two medical centres in South Africa (Violari et 
al., 2008). In Zambia, antiretroviral therapy and once-daily co-trimoxazole prophylaxis reduced mortality 
among HIV-infected children by sixfold, yielding results comparable with those recorded in high-income 
settings (Walker et al., 2007). However, even with the impressive medical outcomes achieved through 
diagnosis and treatment, mortality within the first months of therapy remains high for HIV-infected chil-
dren in sub-Saharan Africa (Bolton-Moore et al., 2007; Bong et al., 2007).
Evidence suggests that improved access to antiretroviral therapy is helping to drive a decline in HIV-
related mortality. This has been conclusively documented in high-income countries, where the benefi-
cial effects of antiretroviral therapy are clearly apparent at the population level (Phillips et al., 2007). 
Similar evidence is starting to emerge from low- and middle-income countries. In the first eight months 
of antiretroviral therapy scale-up in northern Malawi, a population-level reduction in mortality of 35% 
was observed among adults (Jahn et al., 2008). Between 2002–2003 and 2004–2006, during which time 
antiretroviral therapy was introduced in the Umkhanyakude district of KwaZulu-Natal province in South 
Africa, HIV-related mortality among women (aged 25–49) in the district fell by 22% (from 22.52 to 17.58 
per 1000 person-years), while HIV-related death rates among men declined by 29% (from 26.46 to 
18.68 per 1000 person-years) (Herbst et al., 2009). The epidemiological effect of people living with HIV 
for longer because of antiretroviral therapy is that prevalence will be higher compared with if antiretrovi-
ral therapy had not been available.
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In Figures V and VI the red line represents the number of deaths due to AIDS in the scenario where no 
antiretroviral therapy was available; the blue line is the number of deaths estimated given the historical and 
current coverage of antiretroviral therapy. The difference in these values is the estimated number of people 
who are still alive because they had access to antiretroviral therapy between 1996 and 2008. As can be seen in 
Figure V, the global impact of antiretroviral therapy increased dramatically around 2004 and is still increasing.  
Approximately 2.9 million lives have been saved because of access to antiretroviral therapy. Most of the lives 
saved before 2004 were in developed countries. Comparing the impact between regions suggests that the 
number of deaths averted in Western Europe and North America (1.1 million) is similar to the number in sub-
Saharan Africa (1.2 million), despite the much larger epidemic in sub-Saharan Africa. This reflects the much 
longer time period that the drugs have been available in Western Europe and North America than in sub-
Saharan Africa. Figure VI shows the effects in different regions.
Figure V
Estimated number of AIDS-related deaths with and without antiretroviral therapy, globally, 1996–2008
Figure VI 
Estimated number of AIDS-related deaths with and without antiretroviral therapy, by region, 1996–2008
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It is also useful to look at the number of life-years added due to antiretroviral therapy. Life-
years added is a better measure of impact because it facilitates the comparison between 
programmes and allows analysts to assess cost-effectiveness. An estimated 11.7 million life-
years were added globally between 1996 and 2008 as a result of antiretroviral therapy. This 
number will grow quickly in the coming years assuming antiretroviral programmes continue 
to expand at their current rate. Figure VII shows the number of life-years saved by region.
Figure VII
Estimated number of life-years added due to antiretroviral therapy, by region, 1996–2008
In addition to the effects on AIDS mortality and overall HIV prevalence, it is believed 
that improved treatment access could help to lower HIV incidence by reducing the 
viral load at the individual and community level. A recent meta-analysis suggests that 
the transmission rate from a person on antiretroviral therapy is approximately 0.5 per 
100 person-years, while it is 5.6 per 100 person-years for persons not on antiretroviral 
therapy (Attia et al., 2009). Recent mathematical modelling exercises suggest that 
improved access to HIV testing and counselling and to antiretroviral therapy could 
significantly reduce infection rates (Granich et al., 2009; Lima et al., 2008). The 
applicability of such mathematical models to the real world remains uncertain. As 
reported in the chapter on North America and Western and Central Europe, HIV 
incidence appears to be either stable or on the rise in numerous countries where 
antiretroviral therapy has long been widely available. Further research, modelling and 
consultation are recommended regarding the feasibility and effects of the approach 
used in these models (Granich et al., 2009).
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Deriving HIV estimates
The epidemiological estimates summarized in this report are the result of a systematic process 
used by UNAIDS and WHO. Estimates for 2008 build on recent improvements in HIV surveillance 
and estimation methods.
HIV surveillance has historically focused on anonymous epidemiological monitoring in designated 
sites (‘sentinel surveillance’). The number of sentinel surveillance sites has significantly increased in 
recent years. In a growing number of countries, sentinel surveillance has been complemented by 
national population-based surveys that include HIV testing. Since 2001, national HIV surveys have 
been conducted in 31 countries in sub-Saharan Africa, two countries in Asia, one province in each 
of two other countries in Asia and two Caribbean countries. In eight African countries and one 
Caribbean nation, more than one population-based HIV survey has been conducted since 2001, 
permitting an assessment of trends over time. The notable growth in the magnitude and quality of 
HIV epidemiological data has significantly strengthened the reliability of HIV estimates.
Country Country
Sub-Saharan Africa
Benin 1.2 (2006) Nigeria 3.6 (2007)
Botswana 25.0 (2008) Rwanda   3.0 (2005)
25.2 (2004) Senegal   0.7 (2005)
Burkina Faso 1.8 (2003) Sierra Leone 1.5 (2008)
Burundi 3.0 (2007) 1.5 (2005)
3.6 (2002) South Africa 16.9 (2008)
Cameroon   5.5 (2004) 16.2 (2005)
Central African Republic 6.2 (2006) 15.6 (2002)
Chad 3.3 (2005) Swaziland  25.9 (2006–07)
Congo 3.2 (2009) Uganda 6.4 (2004–05)
Côte d'Ivoire 4.7 (2005) United Republic of Tanzania 5.7 (2007)
Democratic Republic of the Congo 1.3 (2007) 7.0 (2004)
Djibouti 2.9 (2002) Zambia 14.3 (2007)
Equatorial Guinea 3.2 (2004) 15.6 (2001–02)
Ethiopia   1.4 (2005) Zimbabwe  18.1 (2005–06)
Ghana 2.2 (2003)
Guinea 1.5 (2005) Asia
Kenya 7.8 (2008) Cambodia   0.6 (2005)
6.7 (2003) India 0.3 (2005–06)
Lesotho   23.4 (2004) Papua province (Indonesia) 2.4 (2006)
Liberia   1.6 (2007) Hai Phong province (Viet Nam)  0.5 (2005)
Malawi 12.7 (2004)
Mali 1.3 (2006) Caribbean
1.8 (2001) Dominican Republic   0.8 (2007)
Niger 0.7 (2006) 1.0 (2002)
0.9 (2002) Haiti  2.2 (2005–06)
HIV prevalence (%) 
(year)
HIV prevalence (%) 
(year)
Adult (aged 15–49) HIV prevalence in (sub-) national population-based surveys that 
included HIV testing, 2001–2008
Sources: demographic health surveys and other national population-based surveys with HIV testing.
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UNAIDS and WHO use three tools to generate HIV estimates for countries and regions: the 
Estimation and Projection Package (EPP), WORKBOOK and Spectrum.1 These models generate 
estimates of HIV prevalence over time, the number of people living with HIV, new infections, 
deaths due to AIDS, children orphaned by AIDS, and treatment needs. These models use data 
from sentinel surveillance, surveys and special studies and are regularly updated on the basis of 
the latest available research. An important new feature of EPP is that it now takes into account the 
impact of treatment coverage on prevalence when estimating incidence. This incidence estimate 
is then used by Spectrum to estimate the numbers of people living with HIV, new infections and 
deaths. Incidence by age group is informed by age patterns of incidence derived from population-
based surveys (Hallett et al., 2008). In addition, EPP now allows for the prevalence trend to be 
informed by multiple population-based surveys and a changing urban–rural ratio over time. As 
previously reported, the availability of more representative data from national population-based 
surveys led to a downward adjustment from previous estimates based solely on antenatal clinic 
surveillance (UNAIDS, 2007). In addition, the models were also adjusted in 2007 to reflect more 
reliable evidence on average survival time, in the absence of treatment, for people living with HIV 
(UNAIDS, 2007).
1 Additional information on these tools is available at http://www.unaids.org/en/knowldgeCentre/HIVData/Methodology/.
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SUB-SAHARAN AFRICA
Number of people living with HIV 2008: 22.4 million  2001: 19.7 million
 [20.8 million–24.1 million] [18.3 million–21.2 million] 
 
Number of new HIV infections 2008: 1.9 million  2001: 2.3 million
 [1.6 million–2.2 million] [2.0 million–2.5 million]  
 
Number of children newly infected 2008: 390 000  2001: 460 000 
 [210 000–570 000] [260 000–640 000]   
  
Number of AIDS-related deaths 2008: 1.4 million 2001: 1.4 million
 [1.1 million–1.7 million] [1.2 million–1.7 million]
In 2008, an estimated 1.9 million [1.6 million–2.2 million] people living in sub-Saharan Africa became 
newly infected with HIV, bringing the total number of people living with HIV to 22.4 million [20.8 million–
24.1 million]. While the rate of new HIV infections in sub-Saharan Africa has slowly declined—with the 
number of new infections in 2008 approximately 25% lower than at the epidemic’s peak in the region in 
1995—the number of people living with HIV in sub-Saharan Africa slightly increased in 2008, in part due to 
increased longevity stemming from improved access to HIV treatment. Adult (15–49) HIV prevalence declined 
from 5.8% [5.5–6.0%] in 2001 to 5.2% [4.9–5.4%] in 2008.
In 2008, an estimated 1.4 million [1.1 million–1.7 million] AIDS-related deaths occurred in sub-Saharan 
Africa. This number represents an 18% decline in annual HIV-related mortality in the region since 2004.
Regional overview
Sub-Saharan Africa remains the region most 
heavily affected by HIV. In 2008, sub-Saharan 
Africa accounted for 67% of HIV infections 
worldwide, 68% of new HIV infections among 
adults and 91% of new HIV infections among 
children. The region also accounted for 72% of the 
world’s AIDS-related deaths in 2008.
The epidemic continues to have an enormous 
impact on households, communities, businesses, 
public services and national economies in the 
region. In Swaziland, average life expectancy 
fell by half between 1990 and 2007, to 37 years 
(United Nations Development Programme, 
2008; Whiteside et al., 2006). In 2008, more than 
14.1 million [11.5 million–17.1 million] children 
in sub-Saharan Africa were estimated to have lost 
one or both parents to AIDS.
Continuing disproportionate impact on 
women and girls
Women and girls continue to be affected dispro-
portionately by HIV in sub-Saharan Africa. For 
example, in Côte d’Ivoire, home to the most serious 
epidemic in West Africa, HIV prevalence among 
females (6.4%) was more than twice as high as 
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among males (2.9%) in 2005 (Institut National de 
la Statistique et al., 2006). In sub-Saharan Africa as 
a whole, women account for approximately 60% of 
estimated HIV infections (UNAIDS, 2008; Garcia-
Calleja, Gouws, Ghys, 2006).
Women’s vulnerability to HIV in sub-Saharan 
Africa stems not only from their greater physi-
ological susceptibility to heterosexual transmission, 
but also to the severe social, legal and economic 
disadvantages they often confront. A recent compre-
hensive epidemiological review undertaken in 
connection with the modes of transmission study 
in Lesotho (see the box ‘Assessing HIV incidence, 
modes of transmission and HIV prevention efforts’) 
found that sexual and physical violence is a key 
determinant of the country’s severe HIV epidemic 
(Khobotlo et al., 2009). According to a recent 
survey, 47% of men and 40% of women in Lesotho 
say women have no right to refuse sex with their 
husbands or boyfriends (Andersson et al., 2007).
The risk of becoming infected is especially dispro-
portionate for girls and young women. In Kenya, 
young women between 15 and 19 years are three 
times more likely to be infected than their male 
counterparts, while 20–24-year-old women are 5.5 
times more likely to be living with HIV than men 
in their age cohort (National AIDS/STI Control 
Programme, 2009). Among people aged 15–24 in 
the United Republic of Tanzania, females are four 
times more likely than males to be living with HIV 
(Tanzania Commission for AIDS et al., 2008). In the 
nine countries in southern Africa most affected by 
HIV, prevalence among young women aged 15–24 
years was on average about three times higher than 
among men of the same age (Gouws et al., 2008).
Individuals who are divorced, separated or widowed 
tend to have significantly higher HIV prevalence 
than those who are single, married or cohabitating, 
with divorced or widowed women experiencing 
especially high prevalence. Often, divorce or 
widowhood stems directly from an individual’s 
HIV status, since many women are often divorced 
because they are diagnosed with HIV and many 
individuals in the region have lost their spouses to 
AIDS-related illnesses. In Guinea, widowed women 
are nearly seven times more likely to be living 
Source: UNAIDS/WHO. 
Number of people living with HIV Adult (15–49) HIV prevalence (%)
Number of people newly infected with HIV Number of adult and child deaths due to AIDS
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with HIV than single women, while divorced or 
separated women are more than three times more 
likely to be infected than their single counterparts 
(Direction Nationale de la Statistique & ORC 
Macro, 2006). More than one in four (27%) of 
widowed Tanzanians are living with HIV, compared 
with 2% of those who have never been married 
and 6% of those who are married or cohabiting 
(National Bureau of Statistics & ORC Macro, 
2005). Widowed individuals in Uganda are more 
than six times more likely to be infected than those 
who have never been married (Uganda Ministry of 
Health & ORC Macro, 2006). 
The relationship between marriage and risk of 
HIV infection is often complex and may vary 
among settings and population groups (Figure 2). 
A national study of uniformed personnel in 
Burundi found that married men had HIV preva-
lence 2.7 times higher than reported for their 
never-married counterparts (Ndayirague et al., 
2008a). However, never having been married is 
not universally protective against HIV infection, 
especially among women; in Lesotho, 24.2% of 
never-married women who have had sex are living 
with HIV (Khobotlo et al., 2009).
HIV prevalence generally tends to peak at a 
younger age for women than for men (Gouws et 
al., 2008). According to household surveys in 28 
countries—all but five in sub-Saharan Africa—
peak HIV prevalence for women occurs between 
the ages of 30 and 34, while men experience the 
highest levels of HIV infection in their late 30s 
and early 40s (Macro International, 2008).
The very young are often at extremely high risk 
of infection through mother-to-child transmission. 
In Swaziland, 5% of children between the ages of 
2 and 4 were HIV-infected in 2006–2007 (Macro 
International, 2008).
Impact across diverse populations
Consistent with the generalized nature of the 
region’s epidemic, HIV affects all social and 
economic groups in sub-Saharan Africa. In 
Lesotho, women and men in every income, educa-
tion and migration strata had an HIV prevalence 
of 15% or higher in 2004 (Khobotlo et al., 2009).
Surveys in different settings in sub-Saharan Africa 
have detected a wide variation in the relationship 
between HIV and income (Piot, Greener, Russell, 
2007). In eight African countries where surveys 
have been conducted (Burkina Faso, Cameroon, 
Ghana, Kenya, Lesotho, Malawi, Uganda and the 
United Republic of Tanzania), HIV prevalence 
is higher among adults in the wealthiest quintile 
than among those in the poorest quintile (Mishra 
et al., 2007). In five of six West African countries 
where survey data are available, women living 
in the wealthiest households have higher HIV 
prevalence than other socioeconomic groups 
of women, but the relationship between wealth 
and HIV is less clear for men in the subregion 
(Lowndes et al., 2008). 
As the epidemic has evolved in sub-Saharan 
Africa, the relationship between HIV infection 
and education has shifted, according to a recent 
meta-analysis of 36 studies carried out in 11 
countries between 1987 and 2003. While studies 
prior to 1996 generally found either no associa-
tion between educational status and HIV risk or 
found that the highest risk was among the most 
educated, data collected after 1996 have tended to 
find a lower risk among the most-educated people 
(Hargreaves et al., 2008).
Assessing HIV incidence, modes of 
transmission and HIV prevention efforts
The UNAIDS Secretariat and Cosponsors 
collaborated in conducting modes of trans-
mission analyses and HIV epidemiology and 
prevention syntheses in 12 countries in sub-
Saharan Africa in 2008–2009. These studies 
used the UNAIDS Incidence Model de-
scribed in Gouws et al. (2006). Developed by 
the UNAIDS Reference Group on Estimates, 
Modelling and Projections, the process and 
model use a variety of epidemiological data 
sources in a country to estimate the distri-
bution of new HIV infections across various 
subgroups of the population in a single year. 
The model does not identify trends in HIV in-
cidence over time. The results should be in-
terpreted with caution as they are influenced 
by a number of assumptions and sometimes 
by uncertain input data. A particularly im-
portant feature of the model is its ability to 
estimate the relative number of new infec-
tions by different modes of exposure.
Estimates of HIV incidence derived by the 
UNAIDS model are coupled with an assess-
ment of HIV prevention spending and pro-
grammatic patterns. This approach enables 
national decision-makers to identify any 
mismatch between programmatic priorities 
and epidemiological patterns and to iden-
tify programmatic or policy gaps in national 
prevention efforts.
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HIV prevalence tends to be higher in urban 
settings than in rural areas, with household surveys 
conducted in the region between 2001 and 2005 
indicating that the median urban/rural ratio of 
HIV prevalence is 1.7:1.0 (Garcia-Calleja, Gouws, 
Ghys, 2006). In the sub-Saharan African countries 
where household surveys have been conducted, 
HIV prevalence is higher in rural areas only in 
Senegal (Macro International, 2008). The most 
pronounced difference in HIV prevalence is in 
Ethiopia, where urban dwellers are eight times 
more likely to be HIV-infected than people living 
in rural areas (Macro International, 2008).
Wide variation within subregional and 
national epidemics
Within countries and subregions, wide variations 
in HIV prevalence and epidemiological patterns 
are frequently apparent. For example, in Kenya 
there is a greater than 15-fold variation in HIV 
prevalence among provinces, ranging from 0.8% in 
North Eastern province to 14.9% in Nyanza prov-
ince (National AIDS/STI Control Programme, 
2009), while the difference between the highest-
prevalence and lowest-prevalence region in the 
United Republic of Tanzania is more than 16-fold 
(Tanzania Commission for AIDS et al., 2008). 
Although the Northwest and North Central 
provinces of Uganda border each other, HIV 
prevalence is nearly four times higher in the latter 
(8.2% versus 2.3%) (Uganda Ministry of Health & 
ORC Macro, 2006).
Adult HIV prevalence in Côte d’Ivoire (3.7%) is 
more than twice as high as in Liberia (1.7%) or 
Guinea (1.6%), even though these West African 
countries share national borders (UNAIDS, 2008). 
Within the relatively small nation of Benin, a more 
than 12-fold variation in HIV prevalence among 
pregnant women (ranging from 0.4% to 3.8%) has 
been documented among the country’s depart-
ments (Bénin Ministère de la Santé, 2008).
Source: Lowndes et al. (2008).
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There is considerable genetic variability in the 
virus within sub-Saharan Africa. A majority of 
infections in the region (56%) in 2005 were esti-
mated to be caused by subtype C, with smaller 
proportions caused by other subtypes (including 
14% by subtype A, 10% by subtype G, 7% by 
CRF02_AG and 9% by other recombinant 
subtypes (Hemelaar et al., 2006)).
Available data suggest that average survival of 
untreated individuals living with HIV in sub-
Saharan Africa is similar to survival in high-income 
countries, but notably longer than survival in Haiti 
and Thailand (Todd et al., 2007). Recent studies 
in Uganda and Kenya found that individuals with 
subtype D appear to experience faster disease 
progression than those with subtype A or C 
(Kiwanuka et al., 2008; Baeten et al., 2007). This 
may have implications for vaccine development 
and for the future spread of HIV.
Impact of treatment scale-up
The rapid scaling-up of antiretroviral therapy 
in sub-Saharan Africa is generating considerable 
public health gains. As of December 2008, 44% of 
adults and children (nearly 3 million people) in 
need of antiretroviral therapy in the region were 
estimated to be receiving such services. Five years 
earlier, the estimated regional treatment coverage 
was only 2% (World Health Organization, United 
Nations Children’s Fund, UNAIDS, 2009).
Antiretroviral therapy coverage is notably higher 
in eastern and southern Africa (48%) than in West 
and Central Africa (30%). Treatment coverage 
for adults (44%) remains higher than for chil-
dren (35%) (World Health Organization, United 
Nations Children’s Fund, UNAIDS, 2009). 
Children’s access to antiretroviral therapy is espe-
cially limited in West and Central Africa—while 
32% of adults in need of therapy in this subre-
gion were estimated to be receiving treatment in 
December 2008, treatment services were reaching 
only 15% of children in need. Early diagnosis 
of HIV infection and initiation of antiretroviral 
therapy in newborns are imperative, as data from 
Zimbabwe demonstrate that infants with perina-
tally acquired HIV are at particular risk of dying 
between two and six months after birth (Marinda 
et al., 2007).
Treatment scale-up is having a profound effect on 
HIV-related mortality in many countries. In Kenya, 
AIDS-related deaths have fallen by 29% since 
2002 (National AIDS Control Council & National 
AIDS/STI Control Programme, 2007). A study in 
Uganda found that timely initiation of antiretroviral 
therapy and co-trimoxazole prophylaxis reduced 
mortality by 95% and also produced a 93% reduc-
tion in HIV-related orphanhood (Mermin et al., 
2008a). In Botswana, where antiretroviral therapy 
coverage exceeds 80%, the estimated annual number 
of AIDS-related deaths has declined by more than 
half—from 15 500 in 2003 to 7400 in 2007—while 
the estimated number of children newly orphaned 
by AIDS has fallen by 40% (Stover et al., 2008).
Important access gaps remain, as more than half 
of all people in need of treatment are still not 
receiving such services. While Kenya was offering 
antiretroviral therapy to roughly 190 000 adults in 
nearly 500 treatment sites in mid-2008, only 12% 
of the estimated 1.4 million HIV-infected adults 
who required daily co-trimoxazole were receiving 
it in 2007 (Kenya Ministry of Health, 2009). 
Increasing knowledge of HIV serostatus
Many countries have taken steps to increase utili-
zation of HIV testing services. Among countries 
for which testing utilization data are available for 
2008, the highest number of tests per 1000 popu-
lation was reported in Botswana (210), Lesotho 
(186), Sao Tome and Principe (179), Uganda (146) 
and Swaziland (139). In Ethiopia, testing rates 
more than doubled between 2007 and 2008—from 
51 tests per 1000 population to 121 tests per 1000 
population (World Health Organization, United 
Nations Children’s Fund, UNAIDS, 2009).
However, considerable gaps remain. While HIV 
testing more than doubled in Kenya between 2003 
and 2007, an estimated 83% of Kenyans living 
with HIV remained undiagnosed in 2007 (Kenya 
Ministry of Health, 2009). Similarly, fewer than 
one in five people in Burundi know their HIV 
status (Ndayirague et al., 2008b). According to a 
household survey in Ethiopia, previously untested 
men and women were more likely to be infected 
than their counterparts who had previously 
accessed testing services (Mishra et al., 2008a).
Recent evidence suggests that inadequate testing 
rates impede national AIDS responses, contributing 
to late entry into medical care for people who are 
HIV-infected and unknowing HIV transmission, 
especially within serodiscordant couples. A house-
hold survey in Uganda indicated that HIV-infected 
individuals who knew their HIV status were more 
than three times more likely to use a condom 
during their last sexual encounter compared with 
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those who did not know their status (Bunnell 
et al., 2008). In rural Zimbabwe, women who 
tested HIV-positive reported increased consistent 
condom use with primary partners, although indi-
viduals testing negative reported an overall increase 
in risky sexual behaviours (Sherr et al., 2007), 
underscoring the need for intensified preven-
tion services to accompany initiatives to promote 
knowledge of HIV serostatus.
Continuing urgent need to strengthen 
HIV prevention
Even with the significant gains that have been 
achieved through treatment scale-up, sub-Saharan 
Africa’s epidemic continues to outpace the response. 
Preserving the long-term viability of treatment 
programmes and mitigating the epidemic’s impact 
in the region requires immediate steps to elevate 
the priority given to HIV prevention and to match 
prevention strategies with actual needs.
In Swaziland, the country with the highest HIV 
prevalence in the world, 17% of total expenditures 
in 2008 supported HIV prevention programmes 
(Mngadi et al., 2009). Between 2005 and 2007, 
prevention spending declined by 43.2% in 
Ghana (Bosu et al., 2009). Prevention spending 
in Lesotho fell by 24% between 2005–2006 and 
2007–2008 (Khobotlo et al., 2009). However, in 
Uganda, prevention resources as a share of national 
HIV-related spending rose from 13% in 2003–
2004 to 33.6% in 2006–2007 (Wabwire-Mangen 
et al., 2009).
Prevention strategies often fail to address the key 
drivers of national epidemics. While people over 
the age of 25 are estimated to account for more 
than two thirds of incident adult infections in 
Swaziland, few prevention programmes specifi-
cally focus on people aged over 25 (Mngadi et 
al., 2009). Likewise, while people in stable rela-
tionships are estimated to account for up to 62% 
of new HIV infections in Lesotho, virtually no 
programmes currently focus on adults, married 
couples or people in long-term relationships 
(Khobotlo et al., 2009). Although sex workers and 
their clients, men who have sex with men and 
injecting drug users together were estimated to 
account for roughly one in three new HIV infec-
tions in Kenya in 2006, only minimal funding has 
been provided for prevention initiatives focused on 
these populations (Gelmon et al., 2009). In Ghana, 
prevention programmes focused on sex workers, 
men who have sex with men and injecting drug 
users consumed 9% of all prevention spending 
in 2007, even though these groups directly or 
indirectly were estimated to account for at least 
38% of new HIV infections in 2008 (Bosu et al., 
2009). In many countries where people in stable 
relationships are responsible for a large proportion 
of new HIV infections, couples testing and other 
prevention services for serodiscordant couples have 
received inadequate support (Gelmon et al., 2009).
State of HIV surveillance
Since 2001, household surveys that include a 
component to assess HIV prevalence have been 
conducted in 28 African countries, including nine 
in 2007 and 2008. Although these surveys vary 
considerably in quality (Garcia-Calleja, Gouws, 
Ghys, 2006), they have provided more representa-
tive population-based estimates of HIV prevalence 
than were possible with previous extrapolations 
from sentinel surveillance of women attending 
antenatal clinics.
An assessment of the quality of serosurveillance 
in low- and middle-income countries between 
2001 and 2007 (including sentinel surveillance and 
national surveys) showed that among 44 coun-
tries that were assessed in this region, 24 had fully 
functional surveillance systems (Lyerla, Gouws, 
Garcia-Calleja, 2008).
Over the past two years, a series of syntheses of 
epidemiological and programmatic data in 11 
African countries has been undertaken. In addi-
tion to characterizing the modes of transmission 
associated with incident HIV infections (Figure 3), 
these analyses have also assessed national preven-
tion strategies. As a result of these efforts, national 
decision-makers have obtained guidance on steps 
to bring national strategies into greater alignment 
with documented prevention needs. 
Despite these improvements, substantial evidence 
gaps remain, which hinders efforts to devise 
evidence-informed AIDS strategies. While there 
has been an important increase in HIV-related 
research involving men who have sex with men 
and injecting drug users in sub-Saharan Africa, 
many countries lack reliable information on the 
size, behaviours and HIV prevalence of these 
populations (see Lowndes et al., 2008).
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Subregional overview
While one in 20 adults in sub-Saharan Africa is esti-
mated to be living with HIV, the severity and nature 
of the epidemic differ by subregion and by country. 
Southern Africa
Southern Africa remains the area most heavily 
affected by the epidemic. The nine countries with 
the highest HIV prevalence worldwide are all 
located in the subregion, with each of these coun-
tries experiencing adult HIV prevalence greater 
than 10%. With an estimated adult HIV prevalence 
of 26% in 2007, Swaziland has the most severe 
level of infection in the world (UNAIDS, 2008). 
Botswana has an adult HIV prevalence of 24%, 
with some evidence of a decline in prevalence in 
urban areas (UNAIDS, 2008). Lesotho’s epidemic 
also appears to have stabilized, with an adult HIV 
prevalence of 23.2% in 2008 (Khobotlo et al., 
2009). South Africa is home to the world’s largest 
population of people living with HIV (5.7 million) 
(UNAIDS, 2008).
For southern Africa as a whole, HIV incidence 
appears to have peaked in the mid-1990s. In 
most countries, HIV prevalence has stabilized 
at extremely high levels, although evidence 
indicates that HIV incidence continues to rise in 
rural Angola. Two rounds of household surveys 
indicate that national HIV incidence significantly 
fell between 2004 and 2008 in the United 
Republic of Tanzania, and a significant drop in 
HIV incidence was also noted among women in 
Zambia between 2002 and 2007 (Hallett et al., in 
press). Zimbabwe has experienced a steady fall in 
HIV prevalence since the late 1990s; studies have 
linked this decline with population-level changes 
in sexual behaviours (Gregson et al., 2006). 
Promising data were also reported from Lusaka, 
where HIV prevalence among young pregnant 
Sources: Bosu et al. (2009) and Mngadi et al. (2009).
Note: sensitivity analysis for Swaziland used different data sources.
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women (17 years or younger) declined from 
12.1% in 2002 to 7.7% in 2006 (Stringer et al., 
2008). Likewise, the percentage of 20–24-year-old 
antenatal clinic attendees who were HIV-infected 
in Botswana fell from 38.7% in 2001 to 27.9% in 
2007 (Botswana Ministry of Health, 2008).
Antenatal surveillance in Swaziland found an 
increase in HIV prevalence, from 39.2% in 2006 
to 42% in 2008, among female clinic attendees 
(Figure 4). There is still no evidence of a decline 
in infections among pregnant women in South 
Africa, where more than 29% of women accessing 
public health services tested HIV-positive in 2008 
(Department of Health, 2009). However, while 
national adult HIV prevalence in South Africa 
has stabilized, prevalence among young people 
(aged 15–24) started to decline in 2005, as shown 
among antenatal clinic attendees (from about 25% 
in 2004–2005 to 21.7% in 2008) and young men 
and women included in the national population-
based surveys (from 10.3% in 2005 to 8.6% in 
2008) (Shisana et al., 2009). 
East Africa
The available evidence suggests that HIV 
prevalence in East Africa has stabilized and in 
some settings may be declining. Declines in HIV 
prevalence reported in Uganda in the past decade 
appear to have reached a plateau (Wabwire-
Mangen et al., 2009), although these trends may 
partly be related to the roll-out of antiretroviral 
therapy programmes.
Reported increases in sexual risk behaviours in 
Uganda remain a source of concern (Opio et al., 
2008), especially as HIV prevalence has increased 
in some antenatal sites (Wabwire-Mangen et al., 
2009). In Burundi, in population-based surveys 
among 15–24-year-olds between 2002 and 2008, 
HIV prevalence declined in urban areas (from 
4.0% to 3.8%) and in semi-urban areas (from 
6.6% to 4.0%), while HIV prevalence increased 
in rural areas from 2.2% to 2.9% (Ministère de 
la Santé Publique & Ministère à la Présidence 
Chargé de la Lutte contre le SIDA, 2002; Conseil 
National de Lutte contre le SIDA, 2008).
Source: Ministry of Health and Social Welfare (2009).
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According to a 2007 household survey in Kenya, 
HIV prevalence has increased since 2003—
from 6.7% to 7.4% (although not statistically 
significant)—reversing the decline reported in 
previous studies. HIV prevalence among adults 
aged 15–49 years in urban areas decreased from 
10.0% in 2003 to 8.7% in 2007, while HIV prev-
alence in rural areas increased from 5.6% to 7.0%. 
Interpretation of these findings remains chal-
lenging. An important factor in Kenya’s increasing 
HIV prevalence is likely to be a decline in 
HIV-related mortality stemming from rapid 
treatment scale-up, although an increase in risky 
sexual behaviour may also be playing a key role 
in the apparent reversal of epidemiological trends, 
especially among rural men. 
West and Central Africa
Although HIV prevalence in West and Central 
Africa is much lower than in southern Africa, 
the subregion nevertheless is home to several 
serious national epidemics. While adult HIV 
prevalence is below 1% in three West African 
countries (Cape Verde, Niger and Senegal), 
nearly one in 25 adults (3.9%) in Côte d’Ivoire 
and 1.9% of the general population in Ghana 
are living with HIV (UNAIDS, 2008). A 2007 
household survey found that HIV prevalence in 
the Democratic Republic of the Congo (1.3%) 
remains significantly lower than in several other 
neighbouring countries (Ministère du Plan & 
Macro International, 2008).
Some further favourable signs are apparent in 
the subregion. Multiple household surveys have 
detected declining HIV prevalence in Mali (from 
1.7% in 2001 to 1.2% in 2006) and Niger (from 
0.9% in 2002 to 0.7% in 2006). In Benin, the 
percentage of antenatal clinic attendees who 
tested HIV-positive fell by almost half between 
2001 and 2007, from 4.1% to 2.1% (Bénin 
Ministère de la Santé, 2008). Declines in HIV 
prevalence among antenatal clinic attendees have 
also been documented in Burkina Faso, Côte 
d’Ivoire and Togo. While HIV prevalence in 
the general population in Ghana has remained 
stable, prevalence among 15–24-year-olds fell 
from 3.2% in 2002 to 2.5% in 2006 (Bosu et al., 
2009). Other national epidemics also appear to 
have stabilized, including in Sierra Leone, where 
population-based surveys in 2005 and 2008 both 
found an overall HIV prevalence of 1.5%.
Key regional dynamics
Heterosexual intercourse remains the primary 
mode of HIV transmission in sub-Saharan Africa, 
with extensive ongoing transmission to newborns 
and breastfed babies. However, as the following 
discussion indicates, recent evidence from epide-
miological studies to estimate the distribution 
of new infections by mode of transmission in 
East, southern and West Africa has shown that 
epidemics in the region are much more varied 
than previously understood, with notable new 
infections occurring among men who have sex 
with men and injecting drug users in some coun-
tries. Emerging evidence confirms elevated HIV 
prevalence among sex workers, although the 
contribution of sex work to new HIV infections 
varies throughout the region.
Heterosexual transmission
Heterosexual exposure is the primary mode of 
transmission in sub-Saharan Africa. In Swaziland, 
transmission during heterosexual contact 
(including sex within stable couples, casual sex and 
sex work) is estimated to account for 94% of inci-
dent infections (Mngadi et al., 2009).
As epidemics in sub-Saharan Africa have matured, 
models suggest that the proportion of new infec-
tions among people in stable, so-called ‘low-risk’, 
partnerships is often high. In Lesotho, between 
35% and 62% of incident HIV infections in 2008 
occurred among people who had a single sexual 
partner (Khobotlo et al., 2009). Heterosexual sex 
within a union or regular partnership accounted 
for an estimated 44% of incident HIV infections 
in Kenya in 2006, while casual heterosexual sex 
accounted for an additional 20% of new infec-
tions (Gelmon et al., 2009). In Uganda, people in 
serodiscordant monogamous relationships were 
estimated to account for 43% of incident infec-
tions in 2008 (Wabwire-Mangen et al., 2009). A 
similar proportion of new infections (50–65%) 
was estimated to occur among steady, long-term 
heterosexual partners in Swaziland (Mngadi et al., 
2009). Low-risk heterosexual contact accounted 
for the largest proportion (30%) of estimated 
incident HIV infections in Ghana in 2008 (Bosu 
et al., 2009), and individuals with only one sexual 
partner are estimated to account for 27–53% of 
new infections in Rwanda (Asiimwe, Koleros, 
Chapman, 2009).
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The significant contribution of low-risk hetero-
sexual partnerships to epidemics in sub-Saharan 
Africa has underscored the high prevalence in 
many countries of serodiscordant partnerships. 
Among married or cohabiting Kenyans who 
were living with HIV in 2007, about 44% had a 
partner who was not infected (Kenya Ministry of 
Health, 2009). According to a household survey 
in Swaziland in 2006–2007, one in six cohabiting 
couples is serodiscordant (Central Statistical Office 
& Macro International, 2008).
Mathematical models have examined the poten-
tial role of concurrent sexual partnerships in 
facilitating the spread of HIV in sexual networks 
(Morris & Kretzschmar, 2000). However, a recent 
analysis of household survey data in 22 coun-
tries, including 18 in sub-Saharan Africa, found 
no significant correlation between prevalence 
of sexual concurrency and HIV prevalence at 
the country or community level (Mishra & 
Bignami-Van Assche, 2009). Given the severity 
of national epidemics in sub-Saharan Africa and 
the relative dearth of information on what might 
be an important factor in the continued spread 
of HIV, the UNAIDS Reference Group on 
Estimates, Modelling and Projections convened 
an expert consultation in April 2009 to identify a 
research agenda on sexual concurrency and HIV. 
In addition to recommending standardization 
of definitions, terminology and methodological 
approaches for measuring sexual concurrency, 
meeting attendees recommended the routine 
collection of pertinent data on sexual concurrency 
and the initiation of focused research studies to 
build the evidence base for an appropriate public 
health response (Garnett, 2009).
As in many other parts of the world, the high 
prevalence of regular non-marital partners among 
married individuals (‘concurrency’) is tacitly 
acknowledged and tolerated in some African 
countries (Mngadi et al., 2009). In Lesotho, 24% 
of adults have multiple sexual partners, often as 
a result of extensive labour migration (Khobotlo 
et al., 2009). In Swaziland, 17.9% of married or 
cohabiting individuals surveyed in 2006–2007 
reported having had two or more sexual partners in 
the previous 12 months (Central Statistical Office 
& Macro International, 2008). However, questions 
in national surveys regarding multiple partners in 
a given time period currently do not distinguish 
between concurrent and serial partnerships.
The 2008 modes of transmission study and 
epidemiological synthesis report in Swaziland 
suggested that the percentage of men having 
multiple partnerships may have fallen in response 
to a public information campaign (Mngadi et 
al., 2009). However, in Uganda, the proportion 
of men (aged 15–49) reporting multiple sexual 
partners increased from 24% in 2001 to 29% in 
2005 (Opio et al., 2008). In 2008, 46% of new 
HIV infections in Uganda were estimated to have 
occurred among people with multiple sexual 
partners and the partners of such individuals 
(Wabwire-Mangen et al., 2009).
Surveys in countries such as Burundi and the 
United Republic of Tanzania have found near-
universal knowledge about HIV (see Tanzania 
Commission for AIDS et al., 2008; Ndayirague 
et al., 2008b), although levels of comprehensive 
knowledge about HIV transmission and its preven-
tion are often much lower.2 In most West African 
countries, the number of women who have 
comprehensive HIV-related knowledge is 10–20% 
lower than the number of men reported to have 
such knowledge (Lowndes et al., 2008). Surveys 
in the United Republic of Tanzania indicate 
that people with higher education and income 
levels also have higher rates of comprehensive 
HIV-related knowledge (Tanzania Commission for 
AIDS et al., 2008).
Evidence suggests that HIV prevention 
programmes may be having an impact on sexual 
behaviours in some African countries. In southern 
Africa, a trend towards safer sexual behaviour was 
observed among both young men and young 
women (15–24 years old) between 2000 and 2007 
(Gouws et al., 2008). In South Africa, the propor-
tion of adults reporting condom use during the 
most recent episode of sexual intercourse rose 
from 31.3% in 2002 to 64.8% in 2008 (Shisana 
et al., 2009). Nevertheless, condom use remains 
low in many parts of sub-Saharan Africa. In 
Burundi, only about one in five people report 
using a condom during commercial sex episodes 
(Ndayirague et al., 2008b), and only 12% of 
2 According to standard monitoring and evaluation indicators, including those used to assess progress in implementing the 
2001 Declaration of Commitment on HIV/AIDS, comprehensive HIV knowledge involves not only accurate understanding of 
the primary modes of HIV transmission and the effectiveness of proven sexual risk reduction methods, but also awareness of 
the inaccuracy of common misconceptions about HIV (e.g. transmission via mosquito bites).
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uniformed personnel in Burundi report using a 
condom with regular partners (Ndayirague et al., 
2008a).
Although data point towards an increased delay in 
initiation of sex among young people (Figure 5) 
in many countries in the region (UNAIDS, 
2008), this is not universally true. In the United 
Republic of Tanzania, where 59% of women 
report becoming sexually active before the age of 
18, surveys in 2007–2008 found little change in 
the age of sexual debut in comparison with the 
previous survey round in 2003–2004 (Tanzania 
Commission for AIDS et al., 2008). Women in the 
United Republic of Tanzania who become sexu-
ally active before the age of 16 have higher HIV 
prevalence (8%) than those who delayed sex until 
age 20 or older (Tanzania Commission for AIDS 
et al., 2008). While the percentage of males aged 
15–24 in South Africa who report sexual debut 
prior to the age of 15 has declined—from 13.1% 
in 2002 to 11.3% in 2008—the percentage of 
young women having sex before the age of 15 
rose from 5.3% to 5.9% (Shisana et al., 2009). In 
Kenya, where the typical young person becomes 
sexually active between the ages of 15 and 19, 
fewer than 25% of young people use a condom 
the first time they have sex (National AIDS/STI 
Control Programme, 2009).
In sub-Saharan Africa, as in some other regions, 
the high prevalence of intergenerational sexual 
partnerships may play an important role in young 
women’s disproportionate risk of HIV infection 
(Leclerc-Madlala, 2008). According to a 2002 
survey of young people aged 12–24 in Lesotho, the 
male partner was at least five years older than the 
female partner in more than half (53%) of all sexual 
relationships and more than 10 years older in 19% 
of sexual relationships (Khobotlo et al., 2009). The 
percentage of young women in South Africa who 
report having a sexual partner more than five years 
older than themselves rose from 18.5% in 2005 to 
27.6% in 2008 (Shisana et al., 2009).
Clinical trials have confirmed the results from 
observational epidemiology that male circumcision 
reduces transmission of HIV among men (Bailey 
et al., 2007; Gray et al., 2007; Auvert et al., 2005). 
In a more recent national survey carried out in 
Kenya, HIV prevalence among uncircumcised men 
Source: Central Statistical Office & Macro International (2008).
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in 2007 was found to be more than three times 
higher (at 13.2%) than among men who were 
circumcised (3.9%) (Kenya Ministry of Health, 
2009). A 2008 analysis of available epidemio-
logical, behavioural and programmatic evidence 
also concluded that the high prevalence of male 
circumcision had helped to limit the epidemic’s 
spread in West Africa (Lowndes et al., 2008). 
Rates of circumcision vary considerably across and 
within countries (Weiss et al., 2008). For example, 
while more than 80% of Kenyan males (aged 
15–64) outside the Nyanza province were circum-
cised in 2007 (Kenya Ministry of Health, 2009), 
only 8% of men in Swaziland are circumcised 
(Mngadi et al., 2009).
Several countries in the region have taken steps 
to scale up medical male circumcision for HIV 
prevention, including Botswana, Kenya and 
Namibia (Forum for Collaborative HIV Research, 
2009). For example, Botswana is integrating male 
circumcision into its national surgery framework, 
with the aim of reaching 80% of males aged 0–49 
by 2013 (Forum for Collaborative Research, 2009). 
As of March 2009, Swaziland had drafted a formal 
male circumcision policy (Mngadi et al., 2009). 
A recent analysis determined that the scale-up of 
adult male circumcision in 14 African countries 
would require considerable funding (an estimated 
US$ 919 million over five years) and substantial 
investments in human resources development, but 
that scale-up would save costs in the long run 
by altering the trajectory of national epidemics 
(Auvert et al., 2008). 
The benefits of male circumcision for the preven-
tion of HIV infection have also prompted 
clinicians and policy-makers to examine strate-
gies for scaling up neonatal circumcision. A recent 
study in South Africa concluded that painless 
circumcision is feasible for nearly all newborns 
if performed within the first week of birth 
(Banleghbal, 2009).
Recent evidence confirms the long-established 
role of untreated sexually transmitted infections 
in accelerating the sexual transmission of HIV. 
For example, according to the results of a 
household survey in Uganda, individuals with 
symptomatic herpes simplex virus type 2 infection 
(HSV-2) are almost four times more likely than 
those without HSV-2 to become infected with 
HIV (Mermin et al., 2008b). These results are 
consistent with an earlier systematic review of 
19 studies that indicates that prevalent HSV-2 
infection was associated with a threefold increased 
risk of HIV acquisition among both men and 
women in the general population (Freeman et 
al., 2006). An epidemiological and economic 
model applied to four diverse settings in East 
and West Africa determined that more than half 
of all new HIV infections could be attributed 
to sexually transmitted infections (White et al., 
2008) and concluded that programmes for treating 
curable sexually transmitted infections may be 
cost-effective in populations with generalized 
epidemics. A longitudinal study of women in 
Uganda and Zimbabwe found that T. vaginalis 
is strongly associated with HIV seroconversion 
(Van der Pol et al., 2008). Surveys in the United 
Republic of Tanzania detected an increase in 
the rates of sexually transmitted infections or 
genital discharges or sores, from 5% among 
women and 6% among men in 2003–2004 to 
6% and 7%, respectively, in 2007–2008 (Tanzania 
Commission for AIDS et al., 2008). Despite the 
consistently demonstrated association between 
HSV-2 and HIV infection, evidence to date does 
not support community-based HSV-2 suppression 
as an effective HIV prevention strategy; in 2008, 
results from a large multicountry study found 
that acilclovir suppressive therapy did not reduce 
HIV acquisition among HIV-negative, HSV-2-
seropositive men and women (Celum et al., 2008).
Heavy alcohol consumption is correlated with 
increased sexual risk behaviours (Van Tieu & 
Koblin, 2009). In Botswana, men who use alcohol 
heavily were more than three times more likely to 
have unprotected sex, to have sex with multiple 
partners and to pay for sex. Similar patterns were 
evident among women in Botswana, with heavy 
alcohol users found to be 8.5 times more likely to 
sell sex than other women. Researchers found a 
strong dose–response relationship between alcohol 
use and risky sexual behaviours, with problem or 
heavy drinkers engaging in greater risk behaviours 
than moderate drinkers (Weiser et al., 2006). 
Sex work
HIV infection among sex workers and their 
clients has long played an important role in the 
heterosexual transmission of HIV in the region. 
For sub-Saharan Africa as a whole, median 
reported HIV prevalence among sex workers is 
19%, with reported prevalence in this population 
ranging from zero in the Comoros and Sierra 
Leone to 49.4% in Guinea-Bissau (World Health 
Organization, United Nations Children’s Fund, 
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UNAIDS, 2009). Seven African countries (Benin, 
Burundi, Cameroon, Ghana, Guinea-Bissau, Mali 
and Nigeria) report that more than 30% of all 
sex workers are living with HIV (World Health 
Organization, United Nations Children’s Fund, 
UNAIDS, 2009). In Ghana, HIV prevalence 
among female sex workers in Accra and Kumasi 
is 8 to 20 times higher than among the general 
population (Bosu et al., 2009). More than one 
in four (25.5%) sex workers surveyed in Benin 
in 2006 were HIV-positive (Bénin Ministère de 
la Santé, 2008). More than one quarter of all sex 
workers (26%) in Lesotho were reported to have 
had a symptomatic sexually transmitted infection 
in the previous year (Khobotlo et al., 2009).
Sex workers are not only a priority population 
for HIV prevention programmes in their own 
right—their clients have long been recognized 
as a potential epidemiological bridge to other 
populations. Extrapolating from the available data, 
researchers concluded in 2008 that between 13% 
and 29% of men in West Africa may have paid for 
sex in the previous year (Lowndes et al., 2008).
As Africa’s epidemics have matured, the portion of 
new infections attributable to sex work may have 
declined (Lecler & Garenne, 2008). In Lesotho, a 
hyperendemic country where the proportion of 
sex workers is estimated to be small, the modes of 
transmission model suggested that sex work was 
the source of approximately 3% of new HIV infec-
tions in 2008 (Khobotlo et al., 2009). 
Nevertheless, sex work continues to play a notable 
role in many national epidemics. In Ghana, sex 
workers, their clients and the sexual partners of 
clients were estimated to account for 2.4%, 6.5% 
and 23%, respectively, of all new HIV infections 
in 2008 (Bosu et al., 2009). In 2006, the modes of 
transmission exercise in Kenya suggested that sex 
workers and their clients accounted for an estimated 
14.1% of incident HIV infections (Gelmon et al., 
2009). Sex workers, their clients and the clients’ 
partners accounted for 10% of incident infections in 
Uganda in 2008 (Wabwire-Mangen et al., 2009). A 
modes of transmission study in Rwanda concluded 
that sex workers accounted for 9–46% of new 
infections in 2008, with the clients of sex workers 
representing an additional 9–11% of incident infec-
tions (Asiimwe, Koleros, Chapman, 2009).
In Kenya, the per-act rate of HIV acquisition in 
female sex workers fell fourfold between 1985 and 
2005, with the fall in HIV risk predating the drop 
in HIV prevalence reported in Kenya’s general 
population in recent years (Kimani et al., 2008). As 
the sharp reduction in HIV risk is consistent with 
decreases in gonorrhoea prevalence, researchers 
speculate that the reduced risk of acquiring HIV 
may stem from improved prevention of sexually 
transmitted infections, although condom use also 
increased dramatically during this period (Kimani 
et al., 2008).
The low social status of sex workers impedes 
efforts to deliver HIV prevention services to this 
population. Surveys in Lesotho indicate that sex 
work is regarded as morally reprehensible, and the 
country’s national AIDS policy explicitly notes 
that the stigma associated with sex work deters sex 
workers from seeking HIV testing or other health 
services (Khobotlo et al., 2009).
Men who have sex with men
In recent years, an increase in research on 
HIV-related risks among men who have sex 
with men in sub-Saharan Africa has detected an 
important, previously undocumented, component 
of many national epidemics (Figure 6). In most 
countries in which such serosurveys have been 
conducted, researchers have identified HIV preva-
lence among men who have sex with men that is 
substantially higher than among the general male 
population (Smith et al., 2009). 
In a study in Mombasa, Kenya, 43.0% of men who 
have sex only with other men tested HIV-positive, 
compared with 12.3% of men who reported 
having sex with both men and women (Sander 
et al., 2007). More than one in four (25.4%) men 
who have sex with men surveyed in Lagos in 2007 
tested HIV-positive (Federal Ministry of Health, 
2007). In a 2008 study of 378 men who have sex 
with men in Soweto, South Africa, researchers 
found an overall HIV prevalence of 13.2%, 
increasing to 33.9% among gay-identified men 
(Lane et al., 2009). One third of men who have 
sex with men surveyed in Cape Town, Durban and 
Pretoria, South Africa, tested HIV-positive (Parry 
et al., 2008). A cross-sectional anonymous survey 
of 537 men who have sex with men in Malawi, 
Namibia and Botswana found HIV prevalences of 
21.4%, 12.4% and 19.7% among study participants 
in the three countries, respectively. HIV prevalence 
among study participants over the age of 30 was 
twice as high as among all men who have sex with 
men surveyed (Baral et al., 2009). In five urban 
sites in Senegal, a low-prevalence country, 21.5% 
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of men who have sex with men surveyed tested 
HIV-positive (Wade et al., 2005).
A recent modes of transmission analysis indicates 
that men who have sex with men may account 
for as many as 20% of incident HIV infections 
in Senegal (Lowndes et al., 2008). In Kenya, men 
who have sex with men (including men in prison 
settings) accounted for an estimated 15% of inci-
dent HIV infections nationwide in 2006 (Gelmon 
et al., 2009). Similarly, a recent modelling exer-
cise concluded that men who have sex with men 
accounted for an estimated 15% of new infections 
in Rwanda (Asiimwe, Koleros, Chapman, 2009). 
In Ghana, men who have sex with men showed 
the highest HIV incidence (9.6%) of any popula-
tion and accounted for 7.2% of all new infections 
in 2008 (Bosu et al., 2009). Reliable data on the 
epidemic’s burden among men who have sex 
with men are not available in many countries (see 
Mngadi et al., 2009).
In studies in Botswana, Malawi and Namibia, lack 
of consistent condom use with male partners was 
significantly associated with HIV infection (Baral 
et al., 2009). The same study also found that many 
men apply petroleum-based lubricants when they 
use a condom, which potentially contributes to 
condom failure (Baral et al., 2009). 
In a study of men who have sex with men in 
Gauteng province in South Africa, the likelihood 
of unprotected anal intercourse was significantly 
associated with regular alcohol drinking (Lane 
et al., 2008). Surveys in Cape Town, Durban and 
Pretoria, South Africa, found that use of crack 
cocaine, methamphetamine and other drugs to 
facilitate sexual encounters is common among 
men who have sex with men (Parry et al., 2008).
Although common in sub-Saharan Africa, homo-
sexual behaviour is highly stigmatized in the 
region. More than 42% of men who have sex with 
men surveyed in Botswana, Malawi and Namibia 
reported experiencing at least one human rights 
abuse, such as blackmail or denial of housing or 
health care (Baral et al., 2009).
More than 30 countries in sub-Saharan Africa 
have laws prohibiting same-sex activity between 
consenting adults (Ottosson, 2009). Punishments 
Source: Smith et al. (2009) and Baral (2009).
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for violations of anti-sodomy laws are often severe, 
with several countries authorizing the death 
penalty and others providing for criminal penal-
ties in excess of 10 years imprisonment (Ottosson, 
2009). In contrast with some other regions, no 
trend towards the repeal of such laws is visible in 
sub-Saharan Africa. In April 2009, Burundi enacted 
the country’s first prohibition of consensual sexual 
contact between members of the same sex. 
Injecting drug use
Although less extensively studied than other key 
populations, injecting drug users in sub-Saharan 
Africa appear to be at high risk of HIV infection. 
In the region as a whole, an estimated 221 000 
injecting drug users are HIV-positive, representing 
12.4% of all injecting drug users in the region 
(Mathers et al., 2008). In Ghana, a modelling 
exercise suggested that injecting drug users had 
an estimated annual seroincidence rate of 4.0% in 
2008 (Bosu et al., 2009). In 2007, 10% of injecting 
drug users surveyed in the Kano region of Nigeria 
tested HIV-positive (Federal Ministry of Health, 
2007). In Nairobi, 36% of injecting drug users 
surveyed tested HIV-positive (Odek-Ogunde et al., 
2004). Survey-based estimates of HIV prevalence 
among injecting drug users in other African coun-
tries range from 12.4% in South Africa to 42.9% 
in Kenya (Mathers et al., 2008).
The lack of reliable evidence on the size of 
national populations of injecting drug users 
inhibits the development of sound prevention 
strategies (see Bosu et al., 2009). In Nigeria, 
researchers found evidence of injecting drug use in 
all regions of the country, but no indication of the 
existence of specific HIV prevention and treatment 
services for drug users (Adelakan & Lawal, 2006).
While studies have often found elevated levels of 
HIV infection among communities of injecting 
drug users in sub-Saharan Africa, this form of 
transmission appears to be significantly outweighed 
by sexual transmission with respect to prevalent 
and incident infections. In Kenya, transmis-
sion during injecting drug use accounted for an 
estimated 3.8% of new HIV infections in 2006 
(Gelmon et al., 2009).
Mother-to-child transmission
As in the case of antiretroviral therapy, sub-
Saharan Africa has made remarkable strides in 
expanding access to services to prevent mother-
to-child HIV transmission. In 2008, 45% of 
HIV-infected pregnant women received anti-
retroviral drugs to prevent transmission to their 
newborns, compared with 9% in 2004 (World 
Health Organization, United Nations Children’s 
Fund, UNAIDS, 2009). However, coverage is 
much higher in eastern and southern Africa 
(64%) than in West and Central Africa (27%) 
(World Health Organization, United Nations 
Children’s Fund, UNAIDS, 2009).
In 2008, an estimated 390 000 [210 000–570 000] 
children were infected in sub-Saharan Africa. As 
services to prevent mother-to-child transmission 
have been brought to scale, the annual number of 
new HIV infections among children has declined 
fivefold in Botswana, from 4600 in 1999 to 890 in 
2007 (Stover et al., 2008). There is also evidence 
that mother-to-child transmission is contributing a 
declining proportion of new infections in Lesotho 
(Khobotlo et al., 2009). Although the vast majority 
of infections in children are the result of mother-
to-child transmission, indications suggest that a 
small proportion of infections in children under 
the age of 15 could be the result of rape or other 
sexual abuse (Khobotlo et al., 2009).
However, mother-to-child transmission continues 
to account for a substantial, although decreasing, 
portion of new HIV infections in many African 
countries. In Swaziland, children were estimated 
to account for nearly one in five (19%) new 
HIV infections in 2008 (Mngadi et al., 2009). 
Perinatally acquired infection accounted for 
15% of new HIV infections in Uganda in 2008 
(Wabwire-Mangen et al., 2009).
Inadequate knowledge about the availability of 
prevention services in antenatal settings often 
impedes their uptake. In the United Republic 
of Tanzania, only 53% of women and 44% of 
men reported awareness that medications and 
other services are available to reduce the risk 
of mother-to-child HIV transmission (Tanzania 
Commission for AIDS et al., 2008).
HIV testing, counselling and prevention services 
in antenatal settings offer an excellent oppor-
tunity not only to prevent newborns from 
becoming infected but also to protect and 
enhance the health of HIV-infected women. In 
numerous countries in which testing data have 
been reported, women are significantly more 
likely than men to know their HIV serostatus, 
in large measure due to the availability of testing 
services in antenatal facilities.
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In 2007, a small study in rural Uganda found that 
women living with HIV who become pregnant 
experience a sharper decline in CD4 cells than 
non-pregnant women, although no statistically 
significant difference was detected between these 
groups in mortality or AIDS diagnosis. The findings 
led the research team to recommend that health-
care providers inform women who are infected 
with HIV of the potential negative immunological 
effect of pregnancy, offer women contraception 
and prioritize pregnant women for antiretroviral 
therapy if eligible (Van der Paal et al., 2007).
Migration
Although mobility is not itself a risk factor for 
HIV, the circumstances associated with move-
ment increase vulnerability to HIV infection. In 
the United Republic of Tanzania, women who 
travelled away from home five or more times in 
the previous 12 months were twice as likely to be 
HIV-positive (12%) as those who did not travel 
(Tanzania Commission for AIDS et al., 2008). In 
rural KwaZulu-Natal province in South Africa, the 
risk of becoming infected was found to increase 
the closer an individual lived to a primary road 
(Bärnighausen et al., 2008).
Consistent with earlier studies among long-
distance truck drivers and migrant mine workers 
(who are more likely to engage in high-risk or 
commercial sex), more recent evidence confirms 
that work-related mobility often significantly 
increases vulnerability to HIV infection. In 
Lesotho, the separation of couples as a result of 
labour migration could also be associated with 
the high rate of multiple concurrent partnerships 
(Khobotlo et al., 2009). Consistent with evidence 
from earlier in the epidemic, recent studies suggest 
that men in high-mobility occupations (such as 
truck drivers) are more likely than other men to 
purchase sex (Lowndes et al., 2008). Modelling 
suggests that migration increases vulnerability to 
HIV primarily by encouraging increased sexual 
risk behaviour rather than by connecting areas of 
high and low risk (Coffee, Lurie, Garnett, 2007).
Prisoners 
Population-based rates of incarceration vary 
substantially among countries in sub-Saharan 
Africa (Dolan et al., 2007). Among 20 countries 
for which HIV prevalence data on prison popula-
tions are available, eight report that at least 10% 
of prisoners are HIV-infected either nationally or 
in parts of the country (Dolan et al., 2007).
Medical injections
A small percentage of prevalent HIV infections 
in sub-Saharan Africa is estimated to stem from 
unsafe injections in medical settings. In an 
analysis in 2004, it was estimated that unsafe 
injections and the use of other contaminated skin 
piercing instruments accounted for 2.5% of all 
HIV infections in the region (Hauri, Armstrong, 
Hutin, 2004). In an analysis of data from Kenya, 
medical injections were estimated to be the 
source of 0.6% of all HIV infections, with blood 
transfusions accounting for an additional 0.2% of 
infections (Gouws et al., 2006).
Analysing serobehavioural survey data from 
Uganda from 2004–2005, researchers in 2008 
concluded that receipt of multiple medical 
injections was significantly associated with HIV 
infection (Mishra et al, 2008b). In Uganda, men 
and women who received five or more medical 
injections in the previous year were significantly 
more likely to be HIV-infected (10.8% and 
11.4% HIV prevalence, respectively) than those 
who received no injections (4.0% and 6.3%, 
respectively). After accounting for other risk 
factors and potential confounding factors, 
men and women who received five or more 
injections were found to be 2.35 times more 
likely to be infected with HIV than those who 
had no injections.
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Asia
Asia, home to 60% of the world’s population, is 
second only to sub-Saharan Africa in terms of the 
number of people living with HIV. India accounts 
for roughly half of Asia’s HIV prevalence.
With the exception of Thailand, every country in 
Asia has an adult HIV prevalence of less than 1%. 
However, owing to the region’s large population, 
Asia’s comparatively low HIV prevalence translates 
into a substantial portion of the global HIV burden.
Notwithstanding its comparatively low HIV 
prevalence, Asia has not escaped the epidemic’s 
harmful consequences. The economic conse-
quences of AIDS will force an additional 6 million 
households in Asia into poverty by 2015 unless 
national responses are significantly strengthened 
(Commission on AIDS in Asia, 2008).
Substantial improvements in HIV surveillance 
systems are evident in many countries. In China, 
for example, the number of HIV surveillance sites 
increased by roughly 20% between 2005 and 2007 
(Wang et al., 2009). Likewise, the first national 
population-based survey in Cambodia generated 
strategic information on HIV prevalence and rele-
vant behaviours in the general population (Sopheab 
et al., 2009). Particular strides have been made in 
improving epidemiological and behavioural data 
regarding the populations most heavily affected by 
the epidemic. For example, Myanmar in 2007 began 
In 2008, 4.7 million [3.8 million–5.5 million] people in Asia were living with HIV, including 350 000 [270 000–410 000] 
who became newly infected last year. Asia’s epidemic peaked in the mid-1990s, and annual HIV incidence has subsequently 
declined by more than half. Regionally, the epidemic has remained somewhat stable since 2000.
In 2008, an estimated 330 000 [260 000–400 000] AIDS-related deaths occurred in Asia. While the annual 
number of AIDS-related deaths in South and South-East Asia in 2008 was approximately 12% lower than the 
mortality peak in 2004, the rate of HIV-related mortality in East Asia continues to increase, with the number of 
deaths in 2008 more than three times higher than in 2000.
Regional overview 
Number of people living with HIV 2008: 4.7 million  2001: 4.5 million
 [3.8 million–5.5 million] [3.8 million–5.2 million]  
Number of new HIV infections 2008: 350 000  2001: 400 000
 [270 000–410 000] [310 000–480 000]   
 
Number of children newly infected 2008: 21 000 2001: 33 000 
 [13 000–29 000] [18 000–49 000]   
  
Number of AIDS-related deaths 2008: 330 000 2001: 280 000 
 [260 000–400 000 ] [230 000–340 000]
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including men who have sex with men in sentinel 
surveillance activities. However, recent reviews have 
emphasized the persistence of information gaps 
regarding populations at higher risk in some parts of 
Asia and the need to further strengthen HIV infor-
mation systems (Wang et al., 2009).
A wide variation in epidemiological patterns 
between different Asian settings is apparent. For 
example, while sexual transmission is driving the 
epidemic throughout most of India, accounting 
for nearly 90% of prevalence nationwide, trans-
mission during injecting drug use is the primary 
transmission mode in the north-eastern part of the 
country (National AIDS Control Organisation, 
2008). In China, while the five highest-prevalence 
provinces account for 53.4% of prevalence, the 
five provinces with the lowest prevalence account 
for less than 1% of total infections (Wang et al., 
2009). In the Papua province of Indonesia, where a 
generalized epidemic similar to the one in neigh-
bouring Papua New Guinea has emerged, HIV 
prevalence is 15 times higher than the national 
average (National AIDS Commission, 2008).
An evolving epidemic
Asia’s epidemic has long been concentrated in 
specific populations, namely injecting drug users, 
sex workers and their clients, and men who have 
sex with men. However, the epidemic in many 
parts of Asia is steadily expanding into lower-risk 
populations through transmission to the sexual 
partners of those most at risk. In China, where the 
epidemic was previously driven by transmission 
during injecting drug use, heterosexual transmis-
sion has become the predominant mode of HIV 
transmission (Wang et al., 2009).
While the regional epidemic appears to be 
stable overall, HIV prevalence is increasing in 
some parts of the region, such as Bangladesh 
and Pakistan. Bangladesh has transitioned from a 
low-level epidemic to a concentrated epidemic, 
with especially elevated rates among injecting 
drug users (Azim et al., 2008). A more prom-
ising picture has emerged in the heavily affected 
Indian states of Andhra Pradesh, Karnataka, 
Maharashtra and Tamil Nadu, where HIV preva-
Source: UNAIDS/WHO. 
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lence among 15–24-year-old women attending 
antenatal clinics declined by 54% between 2000 
and 2007 (Figure 8) (Arora et al., 2008). Likewise, 
a national population-based study in Cambodia 
found an overall HIV prevalence of 0.6%, 
confirming the long-term decline in HIV preva-
lence nationally (Sopheab et al., 2009). 
Regionally, with the growth in transmission 
among the low-risk heterosexual population, 
vigilance is needed in order to prevent the 
epidemic from entering a new period of growth. 
The importance of sustained prevention efforts 
in Asia was confirmed by a recent meta-analysis 
of available data in Viet Nam, which found that 
many low-risk women may be at considerable 
risk of HIV infection due to the high-risk sexual 
and drug-using behaviours of their male partners 
(Nguyen et al., 2008). 
The proportion of women living with HIV in 
the region rose from 19% in 2000 to 35% in 
2008. In particular countries, the growth in HIV 
infections among women has been especially 
striking. In India, women accounted for an 
estimated 39% of prevalence in 2007 (National 
AIDS Control Organisation, 2008). During this 
decade, women’s share of HIV cases in China 
doubled (Lu et al., 2008).
Need for continued vigilance
Although Asia has produced some of the world’s 
most noteworthy national prevention successes, 
many national strategic plans fail to accord suffi-
cient priority to HIV prevention. In a region 
where the heavy concentration of infections in 
discrete populations offers an opportunity to radi-
cally curtail the epidemic’s expansion, the failure 
of many national programmes to prioritize preven-
tion services for populations at higher risk is 
especially worrisome (Commission on AIDS in 
Asia, 2008). 
Thailand provides a vivid illustration of both 
the power of HIV prevention leadership and 
the importance of sustaining a robust response 
over time. With visionary leadership and imple-
mentation of evidence-informed public health 
strategies in the 1990s, Thailand managed to 
arrest an epidemic that threatened to spiral out of 
control. However, after funding for basic preven-
tion services was slashed as a result of the Asian 
economic crisis in the late 1990s, HIV incidence 
subsequently increased. Having intensified national 
Figure 8
Source: Arora et al. (2008). 
Logarithmic trend line; test for trend by logistic regression, with age adjustment to the entire study population, 
n = 202 254 for the south, n = 221 588 for the north.
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prevention efforts, Thailand has again succeeded 
in reducing HIV incidence in recent years 
(Punyacharoensin & Viwatwongkasem, 2009).
As the discussion below reveals, the region does 
not lack models of courageous AIDS leadership. 
Particularly noteworthy are the recent expansion 
of HIV prevention services for traditionally 
marginalized populations in several settings and 
the steps taken in different countries to address 
legal and social impediments to an effective 
response. In China, national financial outlays for 
HIV programmes overall rose more than threefold 
between 2003 and 2006 (State Council AIDS 
Working Committee Office & UN Theme Group 
on AIDS, 2008).
Mixed success on treatment scale-up
The regional picture regarding treatment scale-up 
is mixed. As of December 2008, 37% of those in 
Asia needing antiretroviral therapy were receiving 
it (World Health Organization, United Nations 
Children’s Fund, UNAIDS, 2009), somewhat 
below the global average (42%) for all low- and 
middle-income countries. This represents a seven-
fold increase in treatment access in five years. 
Improvement is needed in promoting widespread 
knowledge of HIV sersostatus (Commission on 
AIDS in Asia, 2008). For example, it is estimated 
that fewer than one in three people living with 
HIV in China have been diagnosed (Wang et al., 
2009).
Key regional dynamics
Asia’s epidemic is diverse, with different transmis-
sion routes predominating in different parts of 
the region. While discrete populations—primarily 
injecting drug users and sex workers and their 
clients—have accounted for most HIV infections, 
onward sexual transmission to the female part-
ners of drug users and the clients of sex workers 
is becoming increasingly apparent. In addition, a 
growing body of data has documented exception-
ally high transmission rates among men who have 
sex with men and transgender people.
Sex work
According to national surveys, the percentage of 
national populations that sell sex ranges from 0.2% 
to 2.6% of the female population, depending on 
the country (Vandepitte et al., 2006). (A survey 
in two urban areas in China generated some-
what higher estimates, finding that sex workers 
accounted for 3.4% to 3.6% of the total female 
urban population (Zhang et al., 2007a).)
Although the total population of female sex workers 
in the region is relatively small, the number of male 
clients is much greater (Commission on AIDS in 
Asia, 2008). In China alone, the number of male 
clients of female sex workers may be as high as 37 
million (Wang et al., 2009). 
In many Asian countries, sex workers are at an 
extremely high risk of infection (Figure 9). In 
Myanmar, for example, more than 18% of female 
sex workers are infected with HIV. In four states of 
southern India, surveys found an HIV prevalence 
of 14.5% among female sex workers (Ramesh et 
al., 2008). Since condoms are not consistently used 
during sex work, sex workers have an elevated risk 
of becoming infected, which in turn can result in 
subsequent transmission to their male clients. In 
China, 60% of female sex workers do not consis-
tently use condoms with their clients (Wang et 
al., 2009). Inadequate condom use during sex 
work risks future HIV outbreaks in settings where 
HIV prevalence is currently low; while a recent 
survey of sex workers in the Hong Kong Special 
Administrative Region found no cases of HIV 
infection, more than half (50.7%) reported having 
failed to use condoms consistently with their male 
clients (Lau et al., 2007).
As in other regions, in Asia there is often consid-
erable overlap between the populations of sex 
workers and injecting drug users (Bokhari et 
al., 2007). In a study of injecting drug users in 
Sichuan province in China, more than 40% of 
females and 34% of males were engaged in sex 
work (Gu et al., 2009).
The sex worker population is not homogenous, 
and sex workers’ various modes of work and life 
patterns may have an important effect on HIV 
risk. In India, brothel-based female sex workers 
are more likely than home-based sex workers to 
be infected with HIV, and the risk is also greater 
for sex workers who are not currently married 
(Ramesh et al., 2008).
Male sex workers are also at high risk of infec-
tion. In Thailand, HIV prevalence among male 
sex workers is more than twice as high as 
among their female counterparts and is currently 
trending upwards (National AIDS Prevention and 
Alleviation Committee, 2008). In Indonesia, HIV 
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Source: Bokhari et al. (2007). 
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prevalence is nearly three times higher among 
male sex workers (20.3%) than among female 
sex workers (7.1%) (National AIDS Commission, 
2008). In the Pakistani cities of Karachi and 
Lahore, 4% of male sex workers are infected with 
HIV (Bokhari et al., 2007). Sex work is common 
among male transgender people (hijras) in South 
Asia (Khan et al., 2008).
Stigma and discrimination against sex workers are 
widespread. Buying or selling sex is widely crimi-
nalized in Asia, although the degree to which such 
laws are enforced often varies. Moreover, when 
laws are enforced, punishment is typically harsher 
for the worker than for the client. In 2009, Taiwan, 
China, began a process of legalizing sex work, due 
at least in part to demands from sex workers for 
equitable treatment.
There is abundant evidence in Asia that sound 
prevention services focusing on sex workers 
can generate substantial public health benefits. 
Beginning with the implementation of the 100 
Percent Condom Programme in brothels, HIV 
prevalence among female sex workers in Thailand 
fell from 33.2% in 1994 to 5.3% in 2007 (National 
AIDS Prevention and Alleviation Committee, 2008).
The Avahan India AIDS Initiative—launched 
by the Bill & Melinda Gates Foundation, with 
ownership now being transitioned to the national 
government—has dramatically expanded preven-
tion services for sex workers in states with a high 
HIV prevalence (Figure 10). Due to the efforts 
of the National AIDS Control Office, Avahan 
and others, prevention services now reach more 
than 80% of female sex workers in four heavily 
affected states (Bill & Melinda Gates Foundation, 
2008). As prevention services for sex workers have 
been brought to scale in high-prevalence areas 
of India, reported condom use during sex work 
is increasing and the prevalence of curable sexu-
ally transmitted infections is on the decline (Bill 
& Melinda Gates Foundation, 2008). Between 
2003 and 2006, HIV prevalence among female 
sex workers in India fell by more than half—
from 10.3% to 4.9% (National AIDS Control 
Organisation, 2008). In Pune, India, female sex 
workers’ risk of becoming infected with HIV 
declined by more than 70% between 1993 and 
2002, and similarly sharp declines in HIV inci-
dence were reported for male clients of sex 
workers, primarily as a result of increased condom 
use (Mehendale et al., 2007).
Sex-trafficked women comprise a subset of 
the population of female sex workers in Asia. 
According to global monitoring of human traf-
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ficking, East Asia is particularly prominent as a 
source of women who are trafficked for sex work: 
East Asian trafficking victims have been detected 
in more than 20 countries worldwide (United 
Nations Office on Drugs and Crime, 2009a). 
Women and girls who have been trafficked to 
India may be contributing to an expansion of 
the epidemic in Nepal. A survey of 246 sex-
trafficked women and girls in Nepal determined 
that 30% were HIV-positive, with HIV-infected 
individuals more likely than their uninfected peers 
to be infected with syphilis and/or hepatitis B 
(Silverman et al., 2008).
Heterosexual transmission
Transmission among sex workers and their clients 
is helping to drive a much broader epidemic of 
heterosexually acquired HIV, resulting in extensive 
transmission among individuals who engage in 
low levels of risk behaviour. Acquisition of HIV 
during heterosexual intercourse is now reported 
as the dominant mode of transmission in China 
(Wang et al., 2009), with the share of heterosexu-
ally acquired incident infections tripling between 
2005 and 2007 (Lu et al., 2008). Likewise, in 
Indonesia an epidemic that was originally confined 
to injecting drug users is now becoming more 
generalized through increased sexual transmission 
(National AIDS Commission, 2008). Increasingly, 
male members of populations at higher risk are 
exposing their female sexual partners to HIV, 
resulting in a steady rise in HIV prevalence among 
low-risk heterosexual women. In Cambodia, 
the age differential between spouses is positively 
correlated with women’s increased risk of HIV 
infection (Sopheab et al., 2009). With a diffuse 
epidemic characterized by considerable hetero-
sexual transmission, Tanah Papua in Indonesia has 
an HIV prevalence of 2.4% in the adult population 
(aged 15–49) (Statistics Indonesia & Ministry of 
Health, 2007).
Source: Avahan and State AIDS Control Society programme data (2008). 
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Source: Chen et al. (2007). 
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Rapid economic development in Asia has been 
accompanied by significant changes in sexual 
patterns. In China, studies indicate that syphilis 
cases have risen dramatically since the early 1990s 
(Figure 11) (Chen et al., 2007). Where such 
evidence is available, behavioural surveys indicate 
a trend towards earlier initiation of sexual activity 
in most Asian countries (Wellings et al., 2006). 
Whether such trends portend an eventual increase 
in heterosexual HIV transmission remains unclear, 
as roughly 95% of prevalent infections among 
young people in Asia are among adolescents at 
higher risk (Economic and Social Commission for 
Asia and the Pacific, 2008).
The popularity of methamphetamine and other 
amphetamine-type stimulants in East and South-
East Asia is cause for concern with respect to the 
risk of sexual HIV transmission. Extensive research 
in both high-income and developing countries 
has correlated use of methamphetamine and other 
amphetamine-type stimulants with sexual risk 
behaviours and HIV infection (Van Tieu & Koblin, 
2009). Up to 20 million people in East and South-
East Asia used amphetamine-type stimulants in 
2007, with powerful methamphetamine serving as 
the drug of choice in this class (United Nations 
Office on Drugs and Crime, 2009b).
Injecting drug users
More than 4.5 million people in Asia are estimated 
to inject drugs. With an estimated 2.4 million 
drug injectors, China is estimated to have the 
world’s largest population of injecting drug users 
(Mathers et al., 2008), although the percentage of 
the national population that injects drugs is higher 
in some other countries. There are estimated to be 
between 70 000 and 300 000 injecting drug users 
in the Islamic Republic of Iran, while the esti-
mated number of injecting drug users in Pakistan 
ranges from 54 000 to 870 000 (Iranian National 
Center for Addiction Studies, 2008). 
In part, the region’s comparatively heavy burden 
of injecting drug use stems from the presence of 
long-standing trafficking routes for illicit opium 
(Lu et al., 2008). Opiates are the drug of choice 
for 65% of Asia’s drug rehabilitation patients, 
although drug use patterns vary greatly within 
the region (United Nations Office on Drugs and 
Crime, 2009b).
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Injecting drug users have some of the highest HIV 
prevalence of any population in Asia. Regionally, 
16% of injecting drug users are believed to be 
HIV-infected (Mathers et al., 2008). However, 
HIV prevalence among drug users is consider-
ably higher in many parts of Asia. In Thailand, 
30–50% of injecting drug users are believed to 
be living with HIV (National AIDS Prevention 
and Alleviation Committee, 2008). More than 
one in three injecting drug users in Myanmar 
(37.5%) are HIV-infected, and nearly one in 
four (23%) injecting drug users in urban settings 
in Pakistan are HIV-positive (Bokhari et al., 
2007). More than half of injecting drug users 
(52%) in Indonesia are living with HIV, with a 
slightly higher prevalence among female injectors 
(National AIDS Commission, 2008). In China, 
estimated HIV prevalence among injecting drug 
users ranges from 6.7% to 13.4% (Wang et al., 
2009). In one prefecture in Yunnan province, 
China, more than half (54%) of injectors are esti-
mated to be HIV-infected (Jia et al., 2008). HIV 
prevalence among injecting drug users exceeds 
10% in seven states in India, according to sentinel 
surveillance undertaken in 2006 (National AIDS 
Control Organisation & National Institute of 
Health and Family Welfare, 2007). In a survey 
of injecting drug users in Kabul, 36.6% of indi-
viduals surveyed exhibited antibodies to hepatitis 
C and 6.5% were antibody-positive for hepatitis 
B (Todd et al., 2007). In the Islamic Republic of 
Iran, injecting drug use accounts for more than 
two thirds (67.5%) of reported HIV cases (Iranian 
National Center for Addiction Studies, 2008). In 
Bangladesh, where very low levels of HIV were 
reported in earlier surveys, a new round of serosur-
veillance in 2006 found that 7% of injecting drug 
users surveyed were HIV-infected in Dhaka  
(Azim et al., 2008).
Injecting drug users in Asia report high rates 
of risk behaviour. Among injecting drug users 
surveyed in Pakistan, two thirds reported sharing 
needles during the previous week (Bokhari et 
al., 2007). Surveys in China indicate that 40% of 
injecting drug users share needles (Wang et al., 
2009).
Regional coverage for harm reduction 
programmes is believed to be extremely low, 
although definitive coverage estimates are not 
currently available in most settings (Commission 
on AIDS in Asia, 2008). The United Nations 
Office on Drugs and Crime estimates that available 
financial resources for harm reduction programmes 
in Asia represent only about 10% of actual need 
(Bergenstrom, 2009).
Several countries in the region have taken steps to 
expand access to evidence-informed strategies to 
prevent new infections among injecting drug users. 
For example, Indonesia revised its national AIDS 
strategy in 2007 to include harm reduction, and 
the country’s supreme judicial court issued a ruling 
that officially prioritized drug rehabilitation over 
incarceration of drug users. UNAIDS regional 
staff in Asia report that access to harm reduction 
has also increased in other countries, including 
Bangladesh, Malaysia and Viet Nam. The Islamic 
Republic of Iran has invested in drug substitution 
programmes, overdose prevention and needle and 
syringe programmes (Iranian National Center for 
Addiction Studies, 2008).
China has launched a major push to expand 
access to harm reduction programmes for drug 
users (Sullivan & Wu, 2007). As of late 2007, more 
than 88 000 drug users had enrolled in metha-
done maintenance treatment programmes, with 
an annual retention rate of 64.5%, and nearly 
50 000 drug users were participating in needle and 
syringe programmes (State Council AIDS Working 
Committee Office & UN Theme Group on 
AIDS, 2008). While policy-makers in China were 
convinced by public health evidence of the effec-
tiveness of harm reduction, a critical ingredient 
for the rapid scaling-up of prevention services for 
drug users has been increased acceptance of the 
approach by public security personnel (Reid & 
Aiken, 2009).
Where harm reduction measures have been imple-
mented, they have slowed the spread of infection. 
For example, after harm reduction programmes 
were introduced in south-western China, annual 
HIV incidence among injecting drug users in the 
area declined by nearly two thirds (Ruan et al., 
2007). In Manipur, India, HIV prevalence among 
injecting drug users and reported needle sharing at 
last injection fell by more than two thirds during 
the seven years after implementation of harm 
reduction programmes (Economic and Social 
Commission for Asia and the Pacific, 2008).
Men who have sex with men
Men who have sex with men in Asia face nearly 
one in five odds (18.7%) of being infected with 
HIV (Baral et al., 2007). In a region where overall 
HIV prevalence is low, high levels of infection 
among men who have sex with men have been 
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Source: Ma et al. (2007). 
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reported in numerous locations—29.3% in 
Myanmar in 2008 (National AIDS Programme, 
2009), 30.7% in Bangkok (Chemnasiri et al., 
2008), 12.5% in Chongqing, China (Feng et al., 
2009), between 7.6% and 18.1% in a study of 
over 4500 self-identified men who have sex with 
men in southern India (Brahmam et al., 2008) and 
between 4% and 32.8% in sentinel surveillance in 
16 cities in India in 2006 (National AIDS Control 
Organisation & National Institute of Health and 
Family Welfare, 2007), 5.6% in Vientiane (Sheridan 
et al., 2009) and 5.2% nationally in Indonesia 
(National AIDS Commission, 2008). In 2007, men 
who have sex with men were estimated to account 
for more than 12% of HIV incidence in China 
(Wang et al., 2009).
Indications suggest that the epidemic among 
men who have sex with men is expanding in 
Asia. Surveillance indicates that the number of 
cases in this population in China is increasing 
(Wang et al., 2009; State Council AIDS Working 
Committee Office & UN Theme Group on 
AIDS, 2008). Periodic surveys of men who have 
sex with men in Bangkok over the past several 
years have likewise detected a steadily increasing 
HIV prevalence (Chemnasiri et al., 2008). In the 
Shandong province of China, HIV prevalence in 
this population rose from 0.05% in 2007 to 3.1% 
in 2008 (Ruan et al., 2009). Separate studies in 
Chongqing, China, also detected a notable increase 
in HIV prevalence among men who have sex with 
men between 2006 and 2007 (Feng et al., 2009), 
and annual surveys in Beijing in 2004, 2005 and 
2006 identified a clear upward trend in prevalence 
(Figure 12) (Ma et al., 2007).
Surveys indicate that a considerable proportion of 
Asian men who have sex with men also have sex 
with women (Sheridan et al., 2009). Recently, a 
number of studies have focused on epidemiolog-
ical and behavioural differences between men who 
have sex only with other men and those who have 
sex with both men and women. In Bangkok, men 
who have sex only with other men are more than 
2.5 times more likely to be HIV-infected than 
men who have sex with both men and women 
(Li et al., 2009). While one study in Jinan, China, 
found that unmarried men who have sex only 
with other men were more than six times more 
likely to be HIV-infected than married men with 
both male and female partners (Ruan et al., 2009), 
another survey in Chongqing, China, determined 
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that married men who have sex with men were 
more than twice as likely to be infected as their 
non-married counterparts (Feng et al., 2009).
Many Asian men who have sex with men engage 
in high rates of risk behaviour. Studies in China, 
Thailand and Viet Nam have found that many 
men who have sex with men have multiple sex 
partners (de Lind van Wijngaarden et al., 2009; 
Ruan et al., 2009; Ruan et al., 2008). For example, 
70% of men who have sex with men surveyed 
in an urban area in China reported having more 
than one sexual partner in the previous six months 
(Wang et al., 2009). Reported condom use among 
men who have sex with men is low (see Ma et al., 
2007; Mansergh et al., 2006). In a survey in the 
Lao People’s Democratic Republic, for example, 
fewer than one in four men who have sex with 
men reported consistent condom use with non-
regular partners (Sheridan et al., 2009). Men who 
have sex with men experience extremely elevated 
rates of syphilis and other sexually transmitted 
infections (Ruan et al., 2008).
A recent study in Bangkok found that the 
percentage of men who have sex with men who 
reported using drugs rose sixfold between 2003 
and 2007—from 3.6% to 20.7%—and the propor-
tion who said that they used drugs during sex 
increased from 0.8% to 6.3% (Chemnasiri et al., 
2008). In a survey of 541 men who have sex with 
men in Beijing, having three or more alcoholic 
drinks a week was significantly associated with 
syphilis infection (Ruan et al., 2008). 
Relatively few epidemiological and behavioural 
studies have been conducted among male trans-
gender people (known as hijras in South Asia) 
in the region. However, evidence indicates that 
the epidemic is heavily affecting transgender 
communities. The National AIDS Commission in 
Indonesia estimates that HIV prevalence among 
the transgender community (waria) ranges from 
3% to 17% (National AIDS Commission, 2008). 
Although a recent study in a city in Pakistan found 
low HIV prevalence (1%) among hijras, 58% had 
a sexually transmitted infection, with 38% having 
multiple infections, and few used condoms (Khan 
et al., 2008). In a survey of men who have sex 
with men in Mumbai, India, men who had sex 
with hijras had higher HIV prevalence than those 
who did not (Hernandez et al., 2006). In a large 
study in southern India, HIV prevalence among 
hijras in 2006 was found to be 18.1% (Brahmam 
et al., 2008).
Widespread stigma and discrimination associ-
ated with same-sex sexual orientation is common 
in the region and is frequently life-threatening. 
Seventeen per cent of men who have sex with 
men surveyed in Vientiane reported suicidal 
ideation, which was the sole variable significantly 
and independently associated with HIV infection 
(Sheridan et al., 2009). Nearly half (45%) of hijras 
surveyed in Pakistan said that they had experi-
enced discrimination on the basis of their sexual 
orientation, and 40% had experienced physical 
abuse or forced sex (Sheridan et al., 2009).
In many cases the social exclusion of men who 
have sex with men is reinforced or institutional-
ized by national legal frameworks. At least 11 
Asian countries have laws that prohibit sexual 
activity between consenting adults of the same 
sex (Ottosson, 2009). In response to a peti-
tion by gay rights groups, the Supreme Court of 
Nepal decreed in 2008 that sexual and gender 
minorities have full constitutional rights. In July 
2009, the High Court in Delhi overturned the 
country’s 150-year-old statute outlawing homo-
sexuality, finding that the law exposed the lesbian, 
gay, bisexual and transgender community to 
“harassment, exploitation, humiliation, cruel and 
degrading treatment”. The Delhi High Court 
also specifically determined that the sodomy law 
impeded access to HIV services by men who have 
sex with men.
In part due to such punitive legal frameworks, the 
community-based infrastructure among men who 
have sex with men has historically been poorly 
developed throughout much of Asia. However, as 
the recent achievements in Nepal and India make 
clear, men who have sex with men and other 
sexual minorities have made remarkable strides in 
recent years in mobilizing their communities for 
advocacy, social support and service delivery. In 
part, this appears to stem from a rapidly developing 
community consciousness in many parts of the 
region. In the northern Chinese city of Harbin, 
the percentage of men who have sex with men 
who self-identify as homosexual rose from 58% in 
2002 to 80% in 2006, and the proportion living 
with a male partner increased from 12% to 41% 
(Zhang et al., 2007b).
Prevention coverage for men who have sex with 
men remains extremely low in Asia (Commission 
on AIDS in Asia, 2008). However, recent expe-
rience demonstrates the feasibility of scaling 
up prevention services for this population. The 
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Avahan India AIDS Initiative and government 
officials report that near universal coverage for 
HIV prevention services has been achieved for 
men who have sex with men in Andhra Pradesh, 
Karnataka and Maharashtra states in India (Bill & 
Melinda Gates Foundation, 2008).
China has also launched a national effort to reach 
men who have sex with men with HIV prevention 
services, supporting and partnering with commu-
nity organizations. However, substantial additional 
progress is required in order to address the preven-
tion needs of this population, as China estimated 
that as of late 2007 it had achieved HIV prevention 
coverage for about 8% of men who have sex with 
men (State Council AIDS Working Committee 
Office & UN Theme Group on AIDS, 2008).
Migrants
Nearly 50 million people in the Asia and Pacific 
region are not living in their country of birth 
(Economic and Social Commission for Asia and 
the Pacific, 2008). However, the number of inter-
national migrants in Asia is vastly outweighed by 
people who migrate internally. China’s so-called 
‘floating population’—generated in large measure 
by migration for work from rural to urban areas—
now approaches 150 million people (National 
Population and Family Planning Commission of 
China, 2008).
Although migration itself is not a risk factor for 
HIV, the circumstances in which migration occurs 
may increase vulnerability to infection. Studies in 
China have found that rural-to-urban migrants 
report frequent substance use and intoxication 
(Chen et al., 2008) and elevated rates of sexually 
transmitted infections (He et al., 2009; Chen 
et al., 2007). In some parts of Asia, such as the 
India–Nepal border, cross-border migration among 
sexual and drug-using networks appears to be 
contributing to a two-way flow of HIV (Nepal, 
2007). Often excluded from basic health services 
in the settings to which they have migrated 
(Economic and Social Commission for Asia and 
the Pacific, 2009), migrants are significantly more 
likely than non-migrants to delay seeking medical 
treatment for infectious diseases (Wang et al., 2008).
Many Asian countries fail to address the role 
of mobility in their national AIDS frameworks, 
although a number of countries, including 
Bangladesh, India and Nepal, have implemented 
HIV prevention initiatives for cross-border 
migrants (Economic and Social Commission for 
Asia and the Pacific, 2009). In response to the 
potential impact of population migration on the 
dynamics of the epidemic, China in 2006 launched 
a national HIV education and communication 
campaign focused on rural-to-urban migrants 
(State Council AIDS Working Committee Office 
& UN Theme Group on AIDS, 2008).
Mother-to-child transmission
An estimated 21 000 [13 000–29 000] children 
under the age of 15 were newly infected with 
HIV in Asia in 2008. To date, mother-to-child 
transmission has been responsible for a relatively 
modest share of new HIV infections in the region. 
In 2007, perinatal transmission accounted for an 
estimated 1.1% of incidence in China (Wang et al., 
2009). 
As of December 2008, 25% of HIV-infected 
pregnant women in the region received antiretro-
viral drugs for the prevention of mother-to-child 
transmission (World Health Organization, United 
Nations Children’s Fund, UNAIDS, 2009). While 
this represents a significant improvement over 
2004, when a regional prevention coverage of 
8% was reported, regional prevention coverage in 
antenatal settings in 2008 was less than the global 
average (45%) for low- and middle-income coun-
tries. The number of new HIV infections among 
children (0–14 years) remains relatively stable in 
South and South-East Asia, although the rate of 
mother-to-child transmission is still increasing in 
East Asia. 
Prisoners
Incarcerated populations in Asia appear to have 
a substantially higher HIV prevalence than the 
general population. In a region where national 
HIV prevalence is relatively low, at least three 
countries (Indonesia, Malaysia and Viet Nam) 
report that HIV prevalence in the prison popu-
lation exceeds 10%. However, HIV-related 
information is not available for the prison systems 
in all countries (Dolan et al., 2007). Access to 
antiretroviral therapy or harm reduction services 
is limited in most prison settings in the region 
(Economic and Social Commission for Asia and 
the Pacific, 2009).
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Number of people living with HIV 2008: 1.5 million  2001: 900 000
 [1.4 million–1.7 million] [800 000 – 1.1 million]  
Number of new HIV infections 2008: 110 000  2001: 280 000
 [100 000–130 000] [240 000–320 000]  
 
Number of children newly infected 2008: 3700  2001: 3000  
 [1700–6000] [1600–4300]    
 
Number of AIDS-related deaths 2008: 87 000 2001: 26 000
 [72 000–110 000] [22 000–30 000]
EASTERN EUROPE AND CENTRAL ASIA
Eastern Europe and Central Asia are considered together because of their physical proximity and their 
common epidemiological characteristics. Epidemics in this region are primarily driven by transmission during 
injecting drug use.
Regional overview
Eastern Europe and Central Asia is the only 
region where HIV prevalence clearly remains 
on the rise (Figure 14). An estimated 110 000 
[100 000–130 000]  people were newly infected 
with HIV in 2008, bringing the number of people 
living with HIV in Eastern Europe and Central 
Asia to 1.5 million [1.4 million–1.7 million], 
compared with 900 000 [800 000–1 000 000] in 
2001, a 66% increase over that time period.
Ukraine and the Russian Federation are 
experiencing especially severe and growing 
national epidemics. With adult HIV prevalence 
higher than 1.6%, Ukraine has the highest 
inflection level reported in all of Europe 
(Kruglov et al., 2008). Overall, estimated HIV 
prevalence exceeds 1% of the adult population in 
three countries in the region (UNAIDS, 2008).
Epidemiological surveillance efforts have 
significantly improved in Eastern Europe and 
Central Asia. These advances have enhanced the 
reliability of epidemiological estimates in the 
region and have expanded the evidence on which 
to base national HIV strategies.
A number of countries in the region have 
expanded access to antiretroviral therapy, 
although treatment coverage remains relatively 
low. By December 2008, 22% of adults in need 
of antiretroviral therapy were receiving it—a 
level less than half the global average for low- 
and middle-income countries (42%). Available 
evidence suggests that injecting drug users—the 
population most at risk of HIV infection in 
Eastern Europe and Central Asia—are often the 
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least likely to receive antiretroviral therapy when 
they are medically eligible (International Harm 
Reduction Development Programme, 2008).
Key regional dynamics
Injecting drug use remains the primary route of 
transmission in the region. In many countries, 
drug users frequently engage in sex work, magni-
fying the risk of transmission. With increasing 
transmission among the sexual partners of drug 
users, many countries in the region are expe-
riencing a transition from an epidemic that is 
heavily concentrated among drug users to one that 
is increasingly characterized by significant sexual 
transmission (Des Jarlais et al., 2009). In addition 
to new infections associated with injecting drug 
use and unprotected sex, key informants and scat-
tered media reports suggest that a notable number 
of new infections may be occurring as a result of 
unsafe injections in health-care settings.
Injecting drug users
Use of contaminated equipment during injecting 
drug use was the source of 57% of newly diag-
nosed cases of HIV infection in Eastern Europe 
in 2007 (van de Laar et al., 2008). An estimated 
3.7 million people in the region currently inject 
drugs, and roughly one in four are believed to be 
HIV-infected (Mathers et al., 2008). 
Exceptionally high HIV prevalence has been 
reported in some countries. Between 38.5% and 
50.3% of injecting drug users in Ukraine are 
believed to be living with HIV (Kruglov et al., 
2008).  In the Russian Federation, 37% of the 
country’s 1.8 million injecting drug users are esti-
mated to be HIV-infected (Mathers et al., 2008).
Evidence indicates that young people account 
for a considerable number of infections among 
injecting drug users in the region. In a study 
involving street youth (aged 15–19) in St. 
Petersburg, Russian Federation, 37.4% of the 
Source: UNAIDS/WHO. 
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people surveyed were HIV-infected, with a 
positive HIV status strongly and independently 
associated with injecting drugs and sharing 
needles (Kissin et al., 2007).
Use of contaminated injecting equipment during 
drug use is an especially efficient means of HIV 
transmission. In Eastern Europe and Central Asia, 
this has sometimes resulted in an extremely rapid 
spread of infection. Whereas HIV infection had 
not been detected among injecting drug users in 
Estonia only a decade ago, one recent survey found 
that 72% of injecting drug users in the country are 
now HIV-infected (Mathers et al., 2008).
Unsafe injecting practices frequently result in 
transmission of blood-borne pathogens other 
than HIV. Hepatitis C prevalence among 
injecting drug users exceeds 25% in nearly all 
European countries and reaches as high as 90% 
(European Monitoring Centre for Drugs and 
Drug Addiction, 2008). Coinfection with hepatic 
diseases may increase the complexity of treatment 
for people living with HIV and may contribute 
to poorer medical outcomes (Treatment Action 
Group, 2008).
A package of services collectively known as ‘harm 
reduction’, which includes needle and syringe 
programmes, drug treatment, including opioid 
substitution therapy, antiretroviral therapy access 
for drug users, and outreach to drug users and 
their sexual partners, has proven effective in signifi-
cantly reducing the risk of HIV transmission via 
injecting drug use (World Health Organization, 
United Nations Office on Drugs and Crime, 
UNAIDS, 2009). HIV prevention coverage for 
injecting drug users remains low in the region. 
However, scattered progress has been reported in 
the region in expanding harm reduction services 
(International Harm Reduction Development 
Programme, 2008). For example, between 2005 
and 2006 the number of sterile syringes distrib-
uted through harm reduction programmes per 
injecting drug user doubled in Estonia, reaching 
112 (European Monitoring Centre for Drugs and 
Drug Addiction, 2008).
Heterosexual transmission
As most injecting drug users are sexually active—
often with non-injecting partners—the existence 
of a major injection-driven epidemic has inevi-
Figure 14
Source: Van de Laar et al. (2008).
Note: data from the Russian Federation not included.
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tably fuelled a growth in heterosexual acquisition 
of HIV in Eastern Europe and Central Asia 
(Des Jarlais et al., 2009; Burchell et al., 2008). In 
Ukraine alone, the number of sexual partners of 
injecting drug users nationally is estimated to be as 
high as 552 500 (Kruglov et al., 2008).
In Eastern Europe, heterosexual transmission 
was the source of 42% of newly diagnosed HIV 
infections in 2007 (van de Laar et al., 2008). 
According to a recent study in the Russian 
Federation, having sex with an injecting drug 
user increased the odds of acquiring HIV by 3.6 
times (Burchell et al., 2008). 
As the rate of heterosexual transmission has 
increased, gender disparities in HIV prevalence are 
narrowing. In Ukraine, women now represent 45% 
of all adults living with HIV (Kruglov et al., 2008). 
Sex workers
The common overlap between sex work and 
injecting drug use further facilitates the spread 
of HIV in the region. In the Russian Federation, 
studies indicate that more than 30% of sex workers 
have injected drugs (UNAIDS, 2008). In Ukraine, 
available evidence indicates that HIV prevalence 
among sex workers ranges from 13.6% to 31.0% 
(Kruglov et al., 2008).
The stigma associated with sex work impedes 
the delivery of effective prevention and treatment 
services to this population. Frequently depicted in 
the popular media as an epidemiological bridge 
to the general population, sex workers in Eastern 
Europe and Central Asia are often ostracized and 
deterred from seeking appropriate services (Beyrer 
& Pizer, 2007). 
Men who have sex with men
Official surveillance figures suggest that trans-
mission among men who have sex with men is 
responsible for a relatively small share of new 
infections in Eastern Europe and Central Asia. In 
2007, sex between men accounted for only 0.4% 
of newly diagnosed infections in Eastern Europe 
(van de Laar et al., 2008). However, informants in 
the region fear that official statistics may signifi-
cantly understate the extent of infection in this 
highly stigmatized population (UNAIDS, 2009). 
Serosurveys throughout the region have detected 
HIV prevalence among men who have sex with 
men ranging from nil in Belarus, Kazakhstan, 
Kyrgyzstan and Lithuania to 5.3% in Georgia 
(Baral et al., 2007), 6% in the Russian Federation 
(van Griensven et al., 2009) and between 10% and 
23% in Ukraine (Kruglov et al., 2008). 
Men who have sex with men not only consti-
tute a priority population itself for prevention 
interventions but may also serve as an important 
epidemiological bridge that facilitates further 
expansion of the epidemic into new populations. 
Extrapolating from behavioural surveys, researchers 
estimate that the number of female sex partners of 
men who have sex with men in Ukraine ranges 
from 177 000 to 430 000 (Kruglov et al., 2008). 
Social exclusion and discriminatory poli-
cies and practices hinder efforts to address the 
epidemic among men who have sex with men. 
Three Central Asian countries prohibit same-sex 
activity between consenting adults (Ottosson, 
2009). In Eastern Europe, at least six countries 
have banned public events for the lesbian, gay 
and bisexual community during the past decade 
(International Lesbian and Gay Association, 2009). 
However, three European countries had, as of 
July 2009, enacted laws to prohibit employment 
discrimination on the basis of sexual orientation 
(International Lesbian and Gay Association, 2009).
Mother-to-child transmission
To date, mother-to-child transmission has played a 
relatively small role in the epidemic’s expansion in 
Eastern Europe and Central Asia. However, with 
the rapid growth of sexual transmission, the risk 
of transmission to newborns may increase. Among 
previously untested pregnant women admitted 
to maternity hospitals in St. Petersburg, Russian 
Federation, 6.5% were found to be HIV-positive 
(Kissin et al., 2008).
One of the signal achievements in the response to 
AIDS in the region has been the high coverage 
achieved of services to prevent mother-to-child 
transmission. In December 2008, estimated 
coverage for prevention of mother-to-child 
transmission in Eastern Europe and Central Asia 
exceeded 90% (World Health Organization, 
United Nations Children’s Fund, UNAIDS, 2009).
Prisoners
Consistent with international patterns, HIV 
prevalence in prison settings appears to be 
significantly higher than in the unincarcerated 
population in Eastern Europe and Central Asia. 
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Surveys in the general prison population found 
HIV prevalence above 10% in several countries, 
with other countries reporting elevated 
infection levels among incarcerated injecting 
drug users (Dolan et al., 2007). According to 
expert informants in the region, many people 
living with HIV move repeatedly in and out of 
prison settings.
In Latvia, estimates suggest that prisoners 
may comprise a third of the country’s total 
population of people living with HIV (United 
Nations Office on Drugs and Crime, World 
Health Organization, UNAIDS, 2008). An 
estimated 10 000 prisoners are living with HIV 
in Ukraine (Kruglov et al., 2008).
In Lithuania, the Russian Federation and 
Ukraine, studies have documented HIV transmis-
sion in prison settings (Dolan et al., 2007). In one 
correctional setting in Lithuania, injecting drug 
use was responsible for a large HIV outbreak, 
with 299 prisoners becoming infected during a 
four-month period (United Nations Office on 
Drugs and Crime, World Health Organization, 
UNAIDS, 2008). Although regional HIV preven-
tion coverage remains inadequate in prison 
settings, several countries have successfully imple-
mented prison-based harm reduction programmes 
(United Nations Office on Drugs and Crime, 
World Health Organization, UNAIDS, 2008). 
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CARIBBEAN
Regional overview
Although it accounts for a relatively small share of 
the global epidemic—0.7% of people living with 
HIV and 0.8% of new infections in 2008—the 
Caribbean has been more heavily affected by 
HIV than any region outside sub-Saharan Africa, 
with the second highest level of adult HIV preva-
lence (1.0% [0.9–1.1%]). AIDS-related illnesses 
were the fourth leading cause of death among 
Caribbean women in 2004 and the fifth leading 
cause of death among Caribbean men (Caribbean 
Epidemiology Centre, 2007).
Although sharp declines in HIV incidence were 
reported in some Caribbean countries earlier 
this decade, the latest evidence suggests that the 
regional rate of new HIV infections has stabilized. 
An apparent exception to the stability of infec-
tion rates is in Cuba, where prevalence is low but 
appears to be on the rise (de Arazoza et al., 2007).
As behavioural data in the region are sparse, it is 
difficult to determine whether earlier declines in 
new infections reflected the natural course of the 
epidemic or the impact of HIV prevention efforts. 
However, a recent review of epidemiological and 
behavioural data in the Dominican Republic 
concluded that the notable declines in HIV 
prevalence reported in that country were likely to 
be due to changes in sexual behaviour, including 
increased condom use and partner reduction, 
although the study also highlighted high levels of 
HIV infection among men who have sex with 
men (Halperin et al., 2009).
Additional efforts to improve HIV surveillance 
in the Caribbean are urgently needed in order to 
obtain a clearer picture of the epidemic and to 
inform national strategic planning (Garcia-Calleja, 
del Rio, Souteyrand, 2009). A considerable share 
(17%) of AIDS cases reported in the Caribbean 
have no assigned risk category; since many 
cases are only officially reported long after the 
diagnosed individual has died, it is often difficult 
or impossible to carry out epidemiological 
investigations (Figueroa, 2008).
National HIV burden varies considerably within 
the region, ranging from an extremely low HIV 
prevalence in Cuba to a 3% [1.9–4.2%] adult 
HIV prevalence in the Bahamas (UNAIDS, 2008). 
Number of people living with HIV 2008: 240 000  2001: 220 000
 [220 000–260 000] [200 000–240 000]  
Number of new HIV infections 2008: 20 000  2001: 21 000
 [16 000–24 000] [17 000–24 000]   
 
Number of children newly infected 2008: 2300 2001: 2800 
 [1400–3400] [1700–4000]    
 
Number of AIDS-related deaths 2008: 12 000 2001: 20 000 
 [9300–14 000] [17 000–23 000]
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The Caribbean has a mixture of generalized and 
concentrated epidemics. 
Women account for approximately half of all infec-
tions in the Caribbean. HIV prevalence is especially 
elevated among adolescent and young women, who 
tend to have infection rates significantly higher 
than males their own age (United States Agency for 
International Development, 2008).
Substantial differences in HIV burden are apparent 
within many Caribbean countries. There is a 
nearly sevenfold variation in HIV prevalence 
between the different regions of the Dominican 
Republic (Pan American Health Organization, 
2008), with HIV prevalence especially elevated in 
the country’s former sugar plantations (bateyes) 
(Centro de Estudios Sociales y Demográficos & 
Measure DHS, 2007). In Haiti, HIV prevalence 
among pregnant women in 2006–2007 ranged 
from 0.75% in a sentinel antenatal site in the 
western part of the country to 11.75% in one 
urban setting (Gaillard & Eustache, 2007).
In part due to collaborative efforts to reduce 
the price of medications, the Caribbean region 
has made important strides towards increasing 
access to HIV treatment. Whereas only 1 in 
10 Caribbean residents in need of treatment 
were receiving antiretroviral drugs in July 2004 
(Pan American Health Organization, 2006), a 
treatment coverage of 51% had been achieved 
as of December 2008, a level higher than the 
global average for low- and middle-income 
countries (42%) (World Health Organization, 
United Nations Children’s Fund, UNAIDS, 
2009). Paediatric antiretroviral coverage in the 
Caribbean (55%) was also higher in December 
2008 than the global treatment coverage level for 
children (38%).
Key regional dynamics
Heterosexual transmission, often tied to sex 
work, is the primary source of HIV transmission, 
although emerging evidence indicates that substan-
tial transmission is also occurring among men who 
have sex with men. 
Source: UNAIDS/WHO. 
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Heterosexual transmission
The majority of AIDS cases reported in the 
Caribbean involve heterosexually transmitted 
infection (Figueroa, 2008). Although it has the 
region’s highest HIV prevalence, Haiti has experi-
enced a notable decline in HIV prevalence since 
the early 1990s; however, this long-term decline 
has flattened in recent years (Gaillard & Eastache, 
2007). According to a 2004 national behavioural 
survey in Jamaica, nearly half (48%) of young men 
(aged 15–24) and 15% of young women had more 
than one sexual partner in the previous 12 months 
(National HIV Program, 2008).
Although behavioural data throughout the region 
are somewhat limited, there is evidence in the 
Dominican Republic of important changes in 
sexual behaviour. In particular, signs suggest that 
the drop in HIV prevalence in that country 
(Figure 16) may be related to increased condom 
use and a reduction in multiple partnerships 
among men (Halperin et al., 2009).
According to 2001 surveys, 2.0% of women in 
Haiti and 1.8% of women in the Dominican 
Republic were involved in sex work (Vandepitte et 
al., 2006). Surveys throughout the Caribbean have 
identified extremely high infection rates among 
sex workers—27% in Guyana in 2005 (Presidential 
Commission on HIV and AIDS, 2008) and 9% in 
Jamaica in 2005 (National HIV Program, 2008). 
Civil society monitoring indicates that a rela-
tively small share of external HIV financing in 
the Caribbean has focused on programmes deliv-
ered by sex worker organizations (International 
HIV/AIDS Alliance, 2009). Although women are 
believed to account for the vast majority of sex 
workers in the Caribbean, emerging evidence 
suggests that male sex workers who sell their 
services to tourists in the region may also face 
considerable risks of acquiring HIV (Padilla, 2007).
Men who have sex with men
Although epidemiological studies involving men 
who have sex with men are relatively rare in 
the Caribbean, the few that exist suggest a high 
burden of HIV infection in this population. A 
2006 study in Trinidad and Tobago found that 
20.4% of men who have sex with men surveyed 
were HIV-infected (Baral et al., 2007), while a 
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subsequent study in Jamaica found HIV prevalence 
of 31.8% (Figueroa et al., 2008). Sex between 
men also appears to be driving an increase in HIV 
prevalence in Cuba (de Arazoza et al., 2007).
Surveys of men who have sex with men in the 
Dominican Republic found that 11% were living 
with HIV and that only about half (54%) reported 
using condoms consistently during anal intercourse 
with another man (Toro-Alfonso, 2005). The 
continuing high prevalence of males among people 
living with HIV in the Dominican Republic, a 
country previously believed to have an epidemic 
overwhelmingly characterized by heterosexual 
transmission, has led researchers to conclude that 
sexual transmission between men may account 
for a much larger share of infections than earlier 
believed (Halperin et al., 2009).
As in many other parts of the world, the stigma 
associated with homosexuality impedes HIV 
prevention initiatives in the Caribbean focused 
on men who have sex with men (Figueroa, 2008). 
At least nine Caribbean countries criminalize 
sexual conduct involving members of the same sex 
(Ottosson, 2009).
Injecting drug use
Transmission during injecting drug use plays 
a relatively modest role in the epidemic in the 
Caribbean. However, a notable exception to this 
pattern is Puerto Rico, where injecting drug use 
represents the most common transmission route; 
it accounted for 40% of HIV incidence among 
males in 2006 and for 27% of new infections 
among females (Centers for Disease Control 
and Prevention, 2009). Puerto Rico, which is 
a legal territory of the USA, had in 2006 an 
HIV incidence rate twice as high as in the USA 
as a whole (Centers for Disease Control and 
Prevention, 2009).
Mother-to-child transmission
As of December 2008, 52% of HIV-infected preg-
nant women in the Caribbean were receiving 
antiretroviral drugs for the prevention of mother-
to-child transmission (World Health Organization, 
United Nations Children’s Fund, UNAIDS, 2009). 
Regional prevention coverage in Caribbean ante-
natal settings exceeds the global average (45%) 
and is an improvement over the regional coverage 
in 2003 (22%). In response to the remaining 
coverage gaps, United Nations stakeholders joined 
with regional partners to launch the Caribbean 
Initiative for the Elimination of the Vertical 
Transmission of HIV and Syphilis.
Prisons
Relatively little data exist on HIV prevalence 
in general prison populations in the Caribbean. 
From information available in three coun-
tries (Cuba, Jamaica and Trinidad and Tobago), 
regional patterns are consistent with those seen 
internationally, with HIV prevalence among pris-
oners (ranging from 4.9% in Trinidad and Tobago 
to 25.8% in Cuba) substantially higher than in 
the general population (Dolan et al., 2007).
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LATIN AMERICA
In 2008, an estimated 170 000 [150 000–200 000] new HIV infections occurred in the region, bringing the 
number of people living with HIV to an estimated 2 million [1.8 million–2.2 million].
Regional overview
The latest epidemiological data suggest that the 
epidemic in Latin America remains stable. With 
a regional HIV prevalence of 0.6% [0.5–0.6%], 
Latin America is primarily home to low-level and 
concentrated epidemics. 
Substantial new evidence on epidemiological 
trends in the region, including the first ever 
modes of transmission analysis for Peru and 
numerous serosurveys among key populations in 
Latin America, has been generated over the past 
two years. As a general rule, however, surveil-
lance systems need to be strengthened in Latin 
America in order to provide a stronger evidence 
base for national planning (Garcia-Calleja, del Rio, 
Souteyrand, 2009).
Due in large measure to the prominence in the 
region’s epidemic of sexual transmission between 
men, the number of HIV-infected men in Latin 
America is substantially higher than the number 
of women living with HIV. For example, in Peru 
the number of male AIDS cases reported in 2008 
was nearly three times higher than the number 
among females, although this 3:1 differential repre-
sents a considerable decline from 1990, when the 
male:female ratio of AIDS cases approached 12:1 
(Alarcón Villaverde, 2009).
Concerns regarding commitment to HIV 
prevention
Latin America offers examples of strong leadership 
on HIV prevention. In particular, Brazil has been 
noted for its early support for evidence-informed 
HIV prevention, which analyses suggest helped 
to mitigate the severity of the country’s epidemic 
(Okie, 2006).
For the region as a whole, however, commitment 
to evidence-informed HIV prevention has 
been highly variable. According to one recent 
analysis, prevention efforts have been hindered 
Number of people living with HIV 2008: 2 million  2001: 1.6 million
 [1.8 million–2.2 million] [1.5 million–1.8 million]  
Number of new HIV infections 2008: 170 000  2001: 150 000
 [150 000–200 000] [140 000–170 000]  
 
Number of children newly infected 2008: 6900 2001: 6200 
 [4200–9700] [3800–9100]    
 
Number of AIDS-related deaths 2008: 77 000 2001: 66 000 
 [66 000–89 000] [56 000–77 000]
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by insufficient attention to human rights and 
sexual health and by inadequate monitoring and 
evaluation (Cáceres & Mendoza, 2009). Even 
though national epidemics in Latin America are 
heavily concentrated among men who have sex 
with men, injecting drug users and sex workers, 
only a small fraction of HIV prevention spending 
in the region supports prevention programmes 
specifically focused on these populations 
(UNAIDS, 2008). In recent years, however, 
Mexico has taken steps to increase funding for 
prevention services focused on men who have 
sex with men (UNAIDS, 2008). 
Above-average treatment coverage
Antiretroviral coverage in Latin America (at 
54% in 2008) is above the global average, with 
especially high coverage achieved in several 
upper-middle-income countries (World Health 
Organization, United Nations Children’s Fund, 
UNAIDS, 2009). In general, treatment coverage is 
higher in South America than in Central America 
(UNAIDS, 2008).
Studies in various localities in Latin America 
have correlated treatment scale-up with notable 
declines in HIV-related mortality (Kilsztajn 
et al., 2007). The most recent epidemiological 
estimates confirm these site-specific findings. In 
2008, 77 000 [66 000–89 000] AIDS-related deaths 
in the region occurred—a 5% decline over the 
HIV-related mortality estimated in 2004. 
Consistent with the evolving state of the art of 
HIV treatment, a growing number of people 
living with HIV in Latin America are initiating 
treatment earlier in the course of infection; 
that is, they are starting treatment when their 
CD4 count has fallen below 350 cells per cubic 
millilitre rather than waiting until their CD4 
count falls below 200. Earlier initiation of therapy 
offers the possibility that medical outcomes in 
the region may improve further still and that 
reductions in the population-level viral load 
may yield additional HIV prevention benefits. In 
Argentina, nearly two thirds (65%) of men who 
have sex with men surveyed in 2007 said that 
Source: UNAIDS/WHO. 
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they had been tested for HIV in the previous 12 
months (Barrón López, Libson, Hiller, 2008).
Key regional dynamics
Men who have sex with men account for the 
largest share of infections in Latin America, 
although there is a notable burden of infection 
among injecting drug users, sex workers and the 
clients of sex workers. The HIV burden appears 
to be growing among women in Central America 
and among indigenous populations and other 
vulnerable groups (Bastos et al., 2008). Divergent 
epidemiological patterns are evident across the 
region, particularly with regard to the contribution 
of injecting drug use to national epidemics.
Men who have sex with men
Epidemiologists estimate that men who have sex 
with men in Latin America have a one in three 
chance of becoming infected with HIV (Baral et 
al., 2007). However, studies point towards substan-
tial variations in HIV prevalence among men who 
have sex with men among Latin American coun-
tries (Cáceres et al., 2008).
Surveys have found HIV prevalence among men 
who have sex with men ranging from 7.9% in 
El Salvador to 25.6% in Mexico and prevalence 
exceeding 10% in 12 out of 14 countries (Baral 
et al., 2007). Surveys in four cities in Argentina 
between 2006 and 2008 found that 11.8% of 
men who have sex with men were HIV-infected 
(Ministerio de Salud, 2009). A 2009 survey of 
urban men who have sex with men in Costa Rica 
determined that 11% of those surveyed were living 
with HIV (Ministerio de Salud de Costa Rica, 
2009). A modes of transmission analysis completed 
in 2009 determined that men who have sex with 
men account for 55% of HIV incidence in Peru 
(Alarcón Villaverde, 2009) (Figure 18).
Source: Alarcón Villaverde (2009).
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The rate of new HIV infections appears to be 
exceptionally high among men who have sex 
with men. Serosurveys in five Central American 
countries detected an annual HIV incidence per 
100 person-years of 5.1 among men who have 
sex with men (Soto et al., 2007). Men who have 
sex with men were 21.8 and 38 times more likely 
than the general population to be infected in El 
Salvador and Nicaragua, respectively (Soto et al., 
2007). In the Central American region, 39% of 
men who have sex with men surveyed reported 
that they do not consistently use condoms with 
casual partners and only 29% reported having been 
reached by HIV prevention programmes (Soto et 
al., 2007). 
The limited evidence suggests HIV prevention 
programmes may be encouraging men who have 
sex with men to adopt safer behaviours. Among 
men who have sex with men in El Salvador, 
condom use during the last episode of sexual 
intercourse rose significantly between 2004 and 
2007, from 70.5% to 82.1% (Population Services 
International, 2008a). Similarly, men who have 
sex with men in Argentina were found to have 
increased condom use between 2004 and 2007 
with both stable and casual partners (Barrón 
López, Libson, Hiller, 2008).
Untreated sexual transmitted infections may be facil-
itating the spread of HIV among men who have sex 
with men. In Peru, newly HIV-infected men who 
have sex with men were roughly four times more 
likely than their uninfected peers to have syphilis or 
herpes simplex virus type 2 (HSV-2) (Sanchez et al., 
2009). According to sentinel surveillance in Central 
America, HSV-2 and syphilis are associated with 
HIV seropositivity (Soto et al., 2007).
As in other regions, the ‘men who have sex with 
men’ label covers a wide array of groups with 
varying sexual identities and socioeconomic status. 
Many men who have sex with men in Latin 
America do not identify themselves as homosexual. 
In El Salvador, which has the highest documented 
HIV prevalence among men who have sex with 
men in Central America, 17% of men who have 
sex with men identify themselves as heterosexual 
(Soto et al., 2007). In urban settings in Peru, 6.5% 
of men who said that they only assumed the active 
role during anal intercourse with other men were 
HIV-infected (Peinado et al., 2007). 
Studies indicate that transgender people in Latin 
America are often at an extremely high risk of 
HIV infection (Cáceres & Mendoza, 2009). In 
2006, 34% of transgender people surveyed in 
Argentina were found to be HIV-infected (Sotelo, 
Khoury, Muiños, 2006). While another study 
in 2002–2006 found a somewhat lower HIV 
prevalence among transgender people tested at 
a local health facility in Argentina (27.6%), the 
study confirmed that infection levels among the 
transgender population are several times higher 
than among other high-risk individuals who 
sought testing services at the same facility (Toibaro 
et al., 2008). A separate survey of transgender 
people in Argentina in 2007 found that nearly 
half (46%) reported having more than 200 sexual 
partners in the previous six months (Barrón López, 
Libson, Hiller, 2008).
Injecting drug users
An estimated 29% of the more than 2 million 
Latin Americans who inject drugs are infected 
with HIV (Mathers et al., 2008). Epidemics among 
injecting drug users in Latin America tend to 
be concentrated in the Southern Cone of South 
America and in the northern part of Mexico, 
along the USA border. (As described below in 
the discussion on heterosexual transmission, there 
is also substantial evidence of sexual transmission 
among users of non-injecting drugs.)
A robust grassroots harm reduction movement 
has long been present in Latin America (Bueno, 
2007). Six countries in the region provide 
various components of harm reduction, 
although opioid substitution therapy is not 
widely available (Cook, 2009).
Sex work
The percentage of the female population engaged 
in sex work in Latin America varies from 0.2% 
to 1.5% (Vandepitte et al., 2006). In Peru, 44% of 
men report having had sex with a sex worker in 
the past (Cáceres & Mendoza, 2009). Serosurveys 
in Central America in recent years have detected 
HIV prevalences among female sex workers of 
4.3% in Guatemala and 3.2% in El Salvador (Soto 
et al., 2007) (Figure 19). 
A significant percentage of Central American sex 
workers are infected with a sexually transmitted 
infection, with especially high rates reported for 
HSV-2 (85% HSV-2 seroprevalence among female 
sex workers in five countries studied) (Soto et 
al., 2007). While most public health attention has 
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focused on preventing HIV transmission among 
female sex workers and their male clients, surveys 
in Argentina indicate that HIV prevalence is signif-
icantly higher among male sex workers (22.8%) 
than among female sex workers (1.8%) in that 
country (Ministerio de Salud, 2009). 
There is a frequent overlap between sex work 
and drug use in the region (Strathdee & Magis-
Rodriguez, 2008). Cocaine injection and the 
non-injection use of methamphetamine are inde-
pendently associated with HIV infection among 
sex workers in Mexico (Patterson et al., 2008).
Emerging evidence suggests that HIV preven-
tion efforts may be having an impact among sex 
workers in Latin America. A five-clinic survey of 
female sex workers in Santiago, Chile, detected 
no HIV infections; sex workers reported always 
using condoms with clients (93.4%), although 
consistent condom use with steady partners was 
rare (9.9%) (Barrientos et al., 2007). A recent study 
in Guatemala found that a multilevel interven-
tion focused on female sex workers resulted in a 
more than fourfold decline in HIV incidence in 
the population, as well as a significant increase in 
consistent condom use (Sabidó et al., 2009). In 
El Salvador, the rate of sex workers’ condom use 
with non-paying partners increased nearly four-
fold between 2004 and 2007 (Population Services 
International, 2008b).
As in other regions, surveys in Latin America 
suggest that sex workers are more likely to use 
condoms with clients than with casual or regular 
partners. A 2008 survey of more than 460 sex 
workers in Honduras found that while 96.7% 
reported consistent condom use with clients, 
frequency of condom use declined to 40.7% with 
casual partners and to 10.6% with regular partners 
(Secretaria de Salud Honduras, 2008) (Figure 20). 
Heterosexual transmission
Although heterosexual transmission outside sex 
work has thus far played a somewhat limited role 
in Latin America’s epidemic, the risk of further 
spread of infection is present. More than one in 
five (22%) men who have sex with men surveyed 
in five Central American countries reported having 
sex with both men and women (Soto et al., 2007). 
Surveys in Peru suggest that non-homosexually-
identified men who only assume the active role 
during anal intercourse with other men may 
Source: Soto et al. (2007).
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Source: Secretaria de Salud Honduras (2008).
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often expose their female sexual partners to HIV 
(Peinado et al., 2007). In Peru, the female sexual 
partners of men who have sex with men account 
for an estimated 6% of HIV incidence (Alarcón 
Villaverde, 2009).
As epidemics mature, the extent of heterosexual 
HIV transmission often increases. According to 
the 2009 modes of transmission study in Peru, 
various forms of heterosexual transmission 
account for 43% of new HIV infections in that 
country, with 16% of all infections stemming 
from so-called ‘low-risk’ sexual activity (Alarcón 
Villaverde, 2009). In the Southern Cone of 
South America, the early establishment of HIV 
among networks of injecting drug users has 
since given rise to increasing transmission among 
low-income heterosexuals (Bastos et al., 2008). 
In Argentina, a survey of 504 non-injecting 
cocaine users found that 6.3% were HIV-infected, 
with infection significantly associated with having 
had a sexual partner who was either an injecting 
drug user or known to be HIV-positive (Rossi 
et al., 2008). More than 40% of HIV-infected 
non-injecting cocaine users in Argentina were 
reactive for antibodies to the hepatitis C virus 
(Rossi et al., 2008).
Individuals with lower educational levels in Latin 
America especially tend towards early initiation 
of sexual activity, which potentially increases their 
risk of HIV acquisition (Bozon, Gayet, Barrientos, 
2009). In Bolivia (Plurinational State of), males 
with post-secondary educational levels are nearly 
three times more likely to use a condom during 
sex with a non-cohabiting partner than their 
counterparts with only a primary education 
(Bolivian Ministry of Health, Macro International, 
Measure DHS, 2008). In Honduras, surveys among 
the ethnic minority Garífuna community found 
low levels of condom use, elevated levels of HIV 
infection (4.5%) and extremely high prevalence 
(51%) of HSV-2 (Paz-Bailey et al., 2009).
Mother-to-child transmission
An estimated 6900 [4200-9700] children under 
the age of 15 were newly infected with HIV in 
Latin America in 2008. As of December 2008, 
Figure 20
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54% of HIV-infected pregnant women in the 
region were receiving antiretroviral drugs to 
prevent transmission to their newborns, compared 
with the global coverage of 45% (World Health 
Organization, United Nations Children’s Fund, 
UNAIDS, 2009); in 2004 the coverage was 23%.
Mobile populations
Cross-border migration between Mexico and 
the USA may be having a considerable effect 
on Mexico’s HIV epidemic. Male injecting 
drug users in Tijuana who had been deported 
from the USA were more than four times 
more likely to be living with HIV than male 
injecting non-deportees (Strathdee et al., 2008). 
In the southern Mexican states of Michoacán 
and Zacatecas, where significant numbers of 
residents travel to the USA for work, more than 
one in five AIDS cases are among individuals 
who resided in the USA (Stathdee & Magis-
Rodriguez, 2008). Almost 50% of men who have 
sex with men in Tijuana (Mexico) report having 
male partners from the USA, while three quarters 
of their peers in nearby San Diego (USA) report 
having sex with Mexican men (Strathdee & 
Magis-Rodriguez, 2008). A survey of more than 
1500 Mexican individuals who had spent time 
in the USA found that migrants had more sexual 
partners and used more non-injecting drugs than 
non-migrants, but migrants also reported higher 
rates of condom use and HIV testing (Magis-
Rodriguez et al., 2009).
Prisoners
Documented HIV prevalence in the general prison 
population exceeds 10% in at least two Latin 
American countries (Argentina and Brazil) (Dolan 
et al., 2007). In a survey of non-injecting cocaine 
users in Argentina, HIV infection was significantly 
associated with previous imprisonment (Rossi et 
al., 2008). Harm reduction programmes are not 
widely available in prison settings in Latin America 
(Cook, 2009), although a number of countries 
are considering the implementation of prevention 
programmes in prisons. 
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NORTH AMERICA AND WESTERN AND 
CENTRAL EUROPE
In 2008, 75 000 [49 000–97 000] new HIV infections occurred in North America and Western and 
Central Europe combined, bringing the total number of people living with HIV in these regions to  
2.3 million [1.9 million–2.6 million].
Regional overview
Progress in reducing the number of new HIV 
infections has stalled in high-income coun-
tries. Between 2000 and 2007, the rate of newly 
reported cases of HIV infection in Europe nearly 
doubled (van de Laar et al., 2008). In 2008, the 
Centers for Disease Control and Prevention (USA) 
estimated that annual HIV incidence has remained 
relatively stable in the USA since the early 1990s, 
although the annual number of new HIV infec-
tions in 2006 (56 300) was approximately 40% 
greater than previously estimated (Hall et al., 
2008a). In Canada, official epidemiological esti-
mates suggest that annual HIV incidence may have 
increased between 2002 and 2005 (Public Health 
Agency of Canada, 2007).
Evolving epidemics
In North America and in Western and Central 
Europe, national epidemics are concentrated 
among key populations at higher risk, especially 
men who have sex with men, injecting drug users 
and immigrants. Within these regions, the rates 
of new HIV infections appear to be highest in 
the USA (Hall et al., 2008a) and Portugal (van de 
Laar et al., 2008).
Although HIV incidence has either remained 
relatively stable or increased slightly in high-
income countries in recent years, epidemiological 
patterns have evolved considerably. In particular, 
evidence indicates that the number of new HIV 
infections among men who have sex with men 
Number of people living with HIV 2008: 2.3 million 2001: 1.9 million
 [1.9 million–2.6 million] [1.7 million–2.1 million]  
Number of new HIV infections 2008: 75 000  2001: 93 000
 [49 000–97 000] [76 000–110 000]  
 
Number of children newly infected 2008: <500 2001: <500 
 [<200–<500] [<200–<500]    
 
Number of AIDS-related deaths 2008: 38 000 2001: 27 000 
 [27 000–61 000] [18 000–42 000]
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Source: UNAIDS/WHO. 
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has increased in the past decade, while rates of 
new infections among injecting drug users have 
fallen. 
Racial and ethnic minorities are more heavily 
affected by the epidemic than other populations 
in many countries. Although African–Americans 
represent 12% of the population of the USA, 
they accounted for 46% of HIV prevalence 
(Centers for Disease Control and Prevention, 
2008a) and 45% of HIV incidence in 2006 (Hall 
et al., 2008a). African–American males in the 
USA have a lifetime risk of HIV seroconversion 
that is 6.5 times higher than that for Caucasian 
males, while African–American females are 19 
times more likely than their Caucasian counter-
parts to become infected (Hall et al., 2008b). In 
Canada, aboriginal people were seven times more 
likely to receive an AIDS diagnosis in 2005 than 
Caucasian people (Hall et al., 2009).
Men outnumber women in both HIV preva-
lence and incidence by more than 2:1 in North 
America and in Western and Central Europe. 
Males accounted for 73% of estimated new HIV 
infections in the USA in 2006 (Centers for 
Disease Control and Prevention, 2008b). HIV 
incidence among women has remained relatively 
stable since the early 1990s (Hall et al., 2008a). 
Females account for 31% of new HIV diagnoses 
in Europe (van de Laar et al., 2008) and for 24% 
of new infections in Canada (Public Health 
Agency of Canada, 2007).
Benefits of antiretroviral therapy
Epidemiological data in high-income countries 
continue to reflect the extraordinary medical 
benefits of antiretroviral therapy. In the USA, the 
number of AIDS-related deaths in 2007 (14 581) 
(Centers for Disease Control and Prevention, 
2009) was 69% lower than in 1994 (47 100) 
(Centers for Disease Control and Prevention, 
1996). In Switzerland, the drop in AIDS-related 
deaths has been even sharper, dropping from 
more than 600 in 1995 to less than 50 in 2008 
(Federal Office of Public Health, 2009) (Figure 22). 
According to the multicountry CASCADE study 
in Europe, Australia and Canada, mortality rates 
among people living with HIV in the first five 
years after infection now approach those in the 
HIV-uninfected population, although excess 
mortality among HIV-infected people increases 
with the duration of infection (Bhaskaran et al., 
2008).
A modelling exercise tested against the available 
epidemiological evidence tracked the steady rise 
Figure 21
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Source: Federal Office of Public Health (2009). 
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in antiretroviral drug utilization in the United 
Kingdom. More than a decade after antiretroviral 
therapy was introduced in the country, 49% of 
all people living with HIV were on antiretroviral 
therapy, with no appreciable increase observed in 
the number of patients with virologic failure or 
resistance to the three original classes of antiret-
roviral drugs (Phillips et al., 2007).
The challenge of late diagnosis
Further progress in reducing HIV-related 
mortality in high-income countries is likely to 
require greater success in encouraging timely 
diagnosis of HIV infection. An estimated 21% 
of people living with HIV in the USA (Centers 
for Disease Control and Prevention, 2008a), 
and 27% in Canada (Public Health Agency of 
Canada, 2007), are unaware of their HIV status. 
In the United Kingdom, nearly one third (31%) 
of people diagnosed with HIV in 2007 had fewer 
than 200 CD4/mm3 within three months of their 
diagnosis (Health Protection Agency, 2008a). 
For Europe as a whole, the percentage of people 
living with HIV who are diagnosed late in the 
course of infection ranges from 15% to 38% 
(Adler, Mounier-Jack, Coker, 2009). In the USA 
in 2006, 36% of people diagnosed with HIV 
received an AIDS diagnosis within 12 months 
(Centers for Disease Control and Prevention, 
2009), while 33% of an HIV-infected cohort in 
France were classified as ‘late testers’ (Delpierre 
et al., 2007). In France, the USA and the United 
Kingdom, people with heterosexually acquired 
HIV infection are most likely to be diagnosed 
late in the course of infection (Delpierre et 
al., 2007; Centers for Disease Control and 
Prevention, 2009; Health Protection Agency, 
2008), while in Switzerland being non-Caucasian 
was associated with late diagnosis (Wolbers et al., 
2008).
Studies indicate that undiagnosed infection facili-
tates ongoing HIV transmission and increases 
susceptibility to early mortality among people 
living with HIV. The Centers for Disease Control 
and Prevention estimates that people who are 
unaware of their HIV-positive status are respon-
sible for up to 70% of new HIV infections in the 
USA; individuals who are unaware of their HIV 
infection are 3.5 times more likely to transmit 
the virus to others than those who know about 
their infection (Marks, Crepaz, Janssen, 2006). 
In New York City, individuals who were diag-
nosed with AIDS within three months of testing 
HIV-positive were more than twice as likely 
to die within four months of their diagnosis as 
patients with an earlier HIV diagnosis (Hanna et 
al., 2008).
Many people diagnosed late in the course of 
infection were never offered an HIV test prior 
Figure 22
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to their diagnosis, notwithstanding their frequent 
visits to health-care settings. Even though HIV 
prevalence among African–American residents of 
Washington, DC, may be as high as 5%, nearly 
half (49%) of sexually active African–Americans 
who saw a health-care provider in the previous 
year were not offered an HIV test (Washington 
DC Department of Health, George Washington 
School of Public Health and Health Services, 
2008). Among African–American and Hispanic 
men who have sex with men surveyed at nine 
gay pride events in the USA in 2004–2006, 74% 
reported having visited a health facility but only 
41% were offered an HIV test (Dowling et al., 
2007).
With the aim of increasing the percentage of 
people who receive a timely diagnosis of HIV, 
the Centers for Disease Control and Prevention 
now recommends routine voluntary HIV testing 
in all health-care settings unless the patient 
expressly opts not to be tested (Centers for 
Disease Control and Prevention, 2006). Several 
other countries have taken steps to streamline the 
process of informed consent in order to increase 
testing uptake.
Key regional dynamics
Epidemics tend to be quite diverse in most 
European and North American countries. A clear 
trend towards increased transmission among men 
who have sex with men is apparent in many 
countries.
Men who have sex with men
Sex between men represents the dominant 
mode of transmission in North America and 
the European Union. A re-emergence of the 
epidemic among men who have sex with men is 
now clearly apparent in many high-income coun-
tries. While the rate of HIV notifications among 
men who have sex with men in North America, 
Western Europe and Australia fell by 5.2% in 
1996–2000, it rose by an annual rate of 3.3% 
between 2000 and 2005. In the USA, the rate 
of new HIV infections among men who have 
sex with men has steadily increased since the 
early 1990s, rising by more than 50% between 
1991–1993 and 2003–2006 (Hall et al., 2008a) 
(Figure 23). HIV diagnoses among men who have 
sex with men in the United Kingdom rose by 
Source: Hall et al. (2008a).
Tick marks denote the beginning and end of a year. The model specified periods within which the number of HIV 
infections was assumed to be approximately constant.
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74% between 2000 and 2007 (Health Protection 
Agency, 2008b). In Europe overall, the number of 
HIV reports among men who have sex with men 
increased by 39% between 2003 and 2007 (van 
de Laar et al., 2008). Similar trends have been 
observed in Canada (Public Health Agency of 
Canada, 2007).
The resurgence in HIV among men who have 
sex with men in high-income countries is 
tied to an increase in sexual risk behaviours. 
In Denmark, the percentage of men who have 
sex with men who engaged in unsafe sex (i.e. 
unprotected anal sex with a partner of unknown 
or different HIV serostatus) rose from 26–28% 
in 2000–2002 to 33% in 2006 (Cowan & Haff, 
2008). In several high-income countries, sharp 
increases in diagnoses of sexually transmitted 
infections other than HIV have been reported 
among men who have sex with men (Health 
Protection Agency, 2008b; Centers for Disease 
Control and Prevention, 2008c).
Heterosexual transmission
The role of heterosexual transmission varies 
notably among national epidemics in high-
income countries. While heterosexual HIV 
transmission accounted for 29% of newly diag-
nosed cases of HIV infection in Western Europe, 
it represented a majority (53%) of new HIV 
diagnoses in Central Europe (van de Laar et al., 
2008). In the USA, the number of new hetero-
sexually acquired HIV infections levelled off in 
the 1990s after increasing steeply in the 1980s; 
in 2006, heterosexual transmission accounted for 
slightly more than one in three new HIV infec-
tions (Hall et al., 2008a). 
Injecting drug users
The role of injecting drug use in national 
epidemics in Europe and North America has 
dramatically declined over the course of the 
epidemic. Although more than 30 000 injecting 
drug users became infected annually with HIV 
in 1984–1986 in the USA, fewer than 10 000 
contracted HIV in 2006 (Hall et al., 2008a).  
In 2007, injecting drug users accounted for 8% 
and 13% of new HIV diagnoses in Western and 
Central Europe, respectively (van de Laar et al., 
2008).
In countries that have invested heavily in harm 
reduction programmes, reductions in drug-
related HIV transmission have been especially 
pronounced. In Switzerland, where transmis-
sion during injecting drug use accounted for 
a majority of HIV diagnoses in the late 1980s 
(Federal Office of Public Health, 2008), this 
mode of transmission accounted for only 4% of 
new HIV infections in 2008 (Federal Office of 
Public Health, 2009). Similarly, injecting drug 
users accounted for 5% of new infections in the 
Netherlands in 2007 (van den Broek et al., 2008). 
The disproportionate risk of death experienced 
by injecting drug users in some settings may also 
help to explain the documented declines in HIV 
prevalence among drug users. While accounting 
for 20.9% of people with diagnosed HIV 
infection in New York City in 2007, injecting 
drug users accounted for 38.1% of all deaths 
among HIV-diagnosed individuals (New York 
City Department of Health and Mental Hygiene, 
2008).
Mother-to-child transmission
Implementation of measures to prevent mother-
to-child HIV transmission has virtually eliminated 
this source of infection in Europe. No new HIV 
infections due to mother-to-child transmission 
were reported in the Netherlands in 2007 (van 
den Broek et al., 2008) or in Switzerland in 2008 
(Federal Office of Public Health, 2008). In the 
United Kingdom, perinatally exposed infants 
accounted for 1.4% of new HIV infections in 
2007 (Health Protection Agency, 2008a). For 
Europe as a whole, the share of new HIV infec-
tions among newborns approaches nil (van de 
Laar et al., 2008). 
Similar, although somewhat more modest, 
declines in HIV incidence among infants have 
been reported in North America. In Canada, the 
HIV infection rate among perinatally exposed 
infants fell from 22% in 1997 to 3% in 2006 
(Public Health Agency of Canada, 2007). In 25 
states in the USA with longstanding HIV infec-
tion reporting systems, the number of annual 
HIV diagnoses among infants dropped from 
130 in 1995 to 64 in 2007 (Centers for Disease 
Control and Prevention, 2009). In New York 
City, the number of newly diagnosed infants 
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fell from 370 in 1992 to 20 in 2005 (New York 
City Department of Health and Mental Hygiene, 
2007).
Prisoners
Evidence has long indicated that HIV preva-
lence among prisoners is higher than among the 
general population. Whereas overall adult HIV 
prevalence in the USA is 0.6% (UNAIDS, 2008), 
1.6% of males and 2.4% of females incarcerated 
in federal and state prison facilities in 2006 were 
living with HIV (Maruschak, 2006). In prison 
facilities in New York State, 12.2% of female 
inmates and 6.0% of male inmates were living 
with HIV in 2006 (Maruschak, 2006).
Mobility
People who acquired HIV infection in their 
countries of origin before migrating to a high-
income country account for a considerable share 
of the epidemic in Europe and North America. 
Of the 4260 people who were newly diagnosed 
with HIV in the United Kingdom in 2007 
and who acquired the virus heterosexually, an 
estimated 77% were believed to have become 
infected outside the UK (Health Protection 
Agency, 2008a). Individuals who were originally 
from countries with a generalized epidemic 
accounted for approximately 17% of new HIV 
diagnoses in Europe in 2007 (van den Broek et 
al., 2008). 
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In 2008, an estimated 35 000 [24 000–46 000] people in the Middle East and North Africa became infected 
with HIV, and 20 000 [15 000–25 000] AIDS-related deaths occurred. The total number of people living with 
HIV in the region at the end of 2008 was estimated to be 310 000 [250 000–380 000].
MIDDLE EAST AND NORTH AFRICA
Regional overview
An acute shortage of timely and reliable epide-
miological and behavioural data has long hindered 
a clear understanding of HIV-related dynamics 
and trends in the Middle East and North Africa. 
Although several countries have taken steps 
to improve HIV information systems, passive 
reporting remains the primary mechanism for 
obtaining evidence on epidemiological and behav-
ioural trends in the region (Shawky et al., 2009). 
In the absence of strategic information about the 
region, various theories about the status of the 
epidemic in the Middle East and North Africa 
have been put forward. While some have asserted 
that cultural values in the region provide a sort of 
‘immunity’ against HIV, others have asserted that 
substantial HIV transmission is occurring but is 
unrecorded.
A recent detailed review of available HIV-related 
data demonstrates that neither ‘cultural immunity’ 
nor an out-of-control epidemic describes the situ-
ation with regard to HIV in the Middle East and 
North Africa (Abu-Raddad et al., 2008). Although 
no country in the region is likely to experience 
an epidemic comparable with the most heavily 
affected countries of sub-Saharan Africa, current 
trends underscore the need for a substantial 
strengthening of AIDS responses in the region. 
The review highlights the urgent need to address 
the pervasive weakness of ongoing monitoring 
efforts in the region. Integrated biobehavioural 
surveys should be conducted regularly among 
priority populations and the results should be 
monitored over time. These studies should be 
complemented by research to estimate the size and 
distribution of priority populations. 
Number of people living with HIV 2008: 310 000  2001: 200 000
 [250 000–380 000] [150 000–250 000]  
Number of new HIV infections 2008: 35 000 2001: 30 000 
 [24 000–46 000] [23 000–40 000]  
 
Number of children newly infected 2008: 4600  2001: 3800  
 [2300–7500] [1900–6400]    
 
Number of AIDS-related deaths 2008: 20 000 2001: 11 000
 [15 000–25 000] [7800–14 000]
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In a region where people between the ages of 15 
and 24 represent one fifth of the total population, 
multicentre studies of vulnerable youth are needed 
(Abu-Raddad et al., 2008). In Egypt, more than 
95% of street children surveyed in 2006 reported 
regularly engaging in sexual behaviour (Shawky et 
al., 2009).
Egypt’s experience in improving HIV-related 
information provides useful guidance on the value 
of strengthening surveillance systems. By under-
taking biobehavioural studies of street children, 
female sex workers, men who have sex with men 
and injecting drug users (Figure 25), Egypt found 
that 6.4% of high-risk males and 14.8% of high-
risk females were HIV-infected in 2006 (Shawky 
et al., 2009). The survey also detected behavioural 
patterns that indicate possible epidemiological 
bridges between key groups and the general popu-
lation and generated critical evidence to inform 
the development and implementation of public 
health policies (Shawky et al., 2009).
Low but increasing HIV prevalence
Throughout most of the region HIV prevalence 
remains low. Exceptions to this general rule are 
evident in Djibouti and southern Sudan, where 
HIV prevalence among pregnant women now 
exceeds 1%. However, even in settings where 
overall HIV prevalence is low, discrete popula-
tions are often heavily affected by the epidemic 
(Abu-Raddad et al., 2008). 
At least two broad epidemiological patterns are 
contributing to the spread of HIV in countries 
of the Middle East and North Africa. First, many 
people in the region are contracting HIV while 
living abroad, often exposing their sexual part-
ners to infection upon their return to their home 
country. The second epidemic driver is transmis-
Source: UNAIDS/WHO. 
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sion within key populations, which may also 
result in ongoing transmission to sexual partners. 
Intensified prevention efforts are needed for the 
female sexual partners of men who are exposed 
to HIV during work abroad, drug use, sex with 
another man or sex with a sex worker. A related 
issue, although one that often manifests itself 
outside the region, involves the large number 
of South Asian men who are guest workers in 
the Middle East and North Africa—anecdotal 
information suggests that guest workers often 
risk becoming infected through contact with sex 
workers in the region, eventually returning home 
to South Asia.
Stronger AIDS responses needed
In most parts of the region, the AIDS response 
remains weak. With 14% of people in need of 
treatment receiving antiretroviral drugs in 2008, 
treatment coverage in the Middle East and North 
Africa was less than half the global average for 
low- and middle-income countries (World 
Health Organization, United Nations Children’s 
Fund, UNAIDS, 2009). Moreover, the pace of 
service expansion is slower in the Middle East 
and North Africa than in other regions. While 
global antiretroviral coverage increased more than 
fourfold between 2004 and 2008, a more modest 
expansion was reported in North Africa and the 
Middle East, with coverage rising from 11% to 
14% in the same four-year period (World Health 
Organization, United Nations Children’s Fund, 
UNAIDS, 2009).
Some progress has been reported in promoting 
knowledge of HIV serostatus, although the 
number of people tested remains low. Between 
2007 and 2008, the number of people receiving 
HIV counselling and testing in Yemen increased 
18-fold—from 121 to 2176 (World Health 
Organization, United Nations Children’s Fund, 
UNAIDS, 2009). In Morocco there was a 24-fold 
rise in the number of people tested between 
2001 and 2007—from 1500 to 35 458 (Morocco 
Health Ministry, 2008).
Key regional dynamics
Epidemics in the Middle East and North Africa are 
typically concentrated among injecting drug users, 
men who have sex with men, and sex workers and 
their clients. Exceptions to this general pattern are 
Djibouti and southern Sudan, where transmission 
is also occurring in the general population.
Figure 25
Source: Shawky et al. (2009). 
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Injecting drug use
Nearly one million people are believed to inject 
drugs in the Middle East and North Africa region, 
which is a region that plays an important role 
in the global drug trade (Abu-Raddad et al., 
2008). Elevated levels of HIV infection have been 
detected in networks of drug users in several 
countries, including mid-range prevalence esti-
mates among injecting drug users of 11.8% in 
Oman, 6.5% in Morocco, 2.9% in Israel, 2.6% in 
Egypt and 2.6% in Turkey (Mathers et al., 2008). 
National HIV prevalence estimates for injecting 
drug users tend to be somewhat lower than the 
figures yielded by surveys in specific localities 
(World Health Organization, United Nations 
Children’s Fund, UNAIDS, 2009).
Data from the available surveys indicate that the 
sharing of injecting equipment is common among 
drug users in the region. In most countries in the 
Middle East and North Africa, most injecting drug 
users are infected with hepatitis C. Most injectors 
are sexually active, but the level of HIV-related 
knowledge is highly variable among drug users in 
the region (Abu-Raddad et al., 2008).
Information on service coverage for harm reduc-
tion programmes for injecting drug users in 
the region is limited. According to information 
provided to WHO in 2009, at least two coun-
tries in the region (Morocco and Oman) offer 
needle and syringe programmes, while Oman 
also provides opioid substitution therapy (World 
Health Organization, United Nations Children’s 
Fund, UNAIDS, 2009). Most harm reduc-
tion programmes in the region are limited to 
small pilot projects (Iranian National Center for 
Addiction Studies, 2008). Morocco reports that 
53% of injecting drug users surveyed reported 
using sterile equipment the last time they injected, 
although only 13% said they used a condom 
during their most recent episode of sexual inter-
course (World Health Organization, United 
Nations Children’s Fund, UNAIDS, 2009). Few 
countries in the region have formally implemented 
comprehensive harm reduction efforts.
Men who have sex with men
Although as common as in other regions, sexual 
contact between men is highly stigmatized in 
the Middle East and North Africa (Abu-Raddad 
et al., 2008). Most countries in the region 
criminalize same-sex activity between consenting 
adults, either through formal statutes or through 
the application of sharia laws that mandate death 
by stoning for individuals who engage in sodomy 
(Ottosson, 2009).
Epidemiological surveys of men who have sex 
with men are relatively rare in the Middle East 
and North Africa, although available evidence 
suggests that this population is heavily affected by 
the epidemic. In Sudan, 9.3% of men who clas-
sified themselves as receptive sexual partners of 
other men were found to be HIV-infected, with 
a somewhat lower prevalence (7.8%) reported 
among ‘active’ men who have sex with men (van 
Griensven et al., 2009). In Egypt, 6.3% of men 
who have sex with men surveyed in 2006 were 
living with HIV (Shawky et al., 2009). Using 
diverse methodological approaches, Morocco esti-
mates that 4% of men who have sex with men are 
HIV-infected, while Lebanon estimates an HIV 
prevalence of 1% in this population (World Health 
Organization, United Nations Children’s Fund, 
UNAIDS, 2009).
Available evidence indicates that many men who 
have sex with men in the Middle East and North 
Africa also have sex with women (Abu-Raddad et 
al., 2008). Only 15% of men who have sex with 
men in Jordan reported using a condom during 
their most recent episode of anal intercourse 
with a male partner (World Health Organization, 
United Nations Children’s Fund, UNAIDS, 2009). 
According to surveys, a significant percentage of 
men who have sex with men also inject drugs and 
use non-injecting drugs (Abu-Raddad et al., 2008). 
Forty-two per cent of men who have sex with 
men in Egypt reported sexual relations with at 
least one sex worker (Shawky et al., 2009).
Although there is evidence that some countries 
in the region have awakened to the epidemic’s 
inroads among men who have sex with men, 
service coverage estimates for this population 
are limited. According to reports to WHO, 13% 
of men who have sex with men in Jordan are 
currently reached by prevention services (World 
Health Organization, United Nations Children’s 
Fund, UNAIDS, 2009).
Sex work
Most studies in the Middle East and North Africa 
have failed to detect high levels of HIV infec-
tion among female sex workers. However, surveys 
of bar-based female sex workers in Djibouti 
73
2 0 0 9  A I D S  E p I D E m I c  u p D A t E  |  m I D D l E  E A S t  A n D  n o r t h  A f r I c A
have found HIV prevalence rates as high as 26%, 
while HIV prevalence among sex workers in 
Yemen has ranged from 1.3% to 7% in multiple 
studies (Abu-Raddad et al., 2008). In Egypt, 0.8% 
of female sex workers surveyed in 2006 were 
HIV-infected (Shawky et al., 2009). Using vari-
able monitoring approaches, national informants 
in Algeria, Morocco and Yemen estimate that, 
respectively, 3.9%, 2.1% and 1.6% of their national 
populations of female sex workers are infected with 
HIV (World Health Organization, United Nations 
Children’s Fund, UNAIDS, 2009). According to 
limited data supplied by countries in 2009, the 
percentage of sex workers who report having used 
a condom during the most recent episode of inter-
course with a client ranged from 44.4% in Jordan 
to 61.1% in Yemen (World Health Organization, 
United Nations Children’s Fund, UNAIDS, 2009).
Only limited evidence exists regarding HIV 
transmission to sex workers’ male clients, who 
may subsequently expose their wives or other 
female sex partners to the virus. Some experts 
have suggested that the near universal circumci-
sion of males in the region may slow the potential 
secondary spread of infection from male clients 
to their primary female partners (Abu-Raddad et 
al., 2008). However, an earlier study of 410 people 
living with HIV in Saudi Arabia found that 90% of 
males with heterosexually acquired HIV became 
infected as a result of intercourse with a female sex 
worker (Abdulrahman, Halim, Al-Abdely, 2004). 
Information on HIV prevention service coverage 
for sex workers is not available from most coun-
tries in the region. 
Mother-to-child transmission
In 2008, 4600 [2300–7500] children became 
newly infected with HIV in the region. Prevention 
coverage in antenatal settings remains virtually 
non-existent in the region, with regional coverage 
below 1% as of December 2008 (World Health 
Organization, United Nations Children’s Fund, 
UNAIDS, 2009).
Prisons
The limited evidence indicates that prisoners 
experience significantly higher levels of HIV 
infection than the general population in the 
region. HIV prevalence among the general 
prison population reportedly exceeds 10% in 
Yemen, with elevated HIV prevalence reported 
among drug-using prison inmates in the Islamic 
Republic of Iran and the Libyan Arab Jamahiriya 
(Dolan et al., 2007). In Morocco, HIV preva-
lence among prisoners fell by half between 2002 
and 2007, from 1.2% to 0.6% (Morocco Health 
Ministry, 2008).
Blood safety
Transmission resulting from blood transfusions, 
organ transplants or renal dialysis accounts for a 
considerable percentage of HIV prevalence in the 
region. In Egypt, 6.2% of reported AIDS cases are 
due to receipt of blood products, while 12% stem 
from renal dialysis (Shawky et al., 2009). Blood 
transfusions are reported to be the mode of trans-
mission for 6% of HIV prevalence in Lebanon 
(Shawky et al., 2009). In Saudi Arabia, 12% of 
people living with HIV contracted their infec-
tion through blood transfusions, while another 
1.5% became infected due to an organ transplant 
(Abdulrahman, Halim, Al-Abdely, 2004). Data 
from Saudi Arabia suggest that the role of blood 
transfusions as a source of HIV infection has 
declined (Abdulrahman, Halim, Al-Abdely, 2004).
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OCEANIA
In 2008, 3900 [2900–5100] new HIV infections occurred in the Oceania region, bringing the total number of 
people living with HIV to 59 000 [51 000–68 000].
Regional overview
There is generally a very low HIV prevalence in 
Oceania compared with other regions. In the small 
island nations that make up most of the countries 
in the region, adult HIV prevalence tends to be 
well below 0.1%. Likewise, with an estimated 
HIV prevalence of 0.2%, Australia’s epidemic is 
considerably less severe than those of any other 
high-income country. National epidemics in 
Oceania are overwhelmingly driven by sexual HIV 
transmission, although the specific populations 
most affected vary substantially within the region.
Infections on the rise in some countries
One notable exception to the preponderance 
of low-level epidemics is Papua New Guinea, 
which is experiencing an expanding, generalized 
epidemic. Excluding the high-income countries 
of Australia and New Zealand, Papua New 
Guinea accounted for more than 99% of reported 
HIV diagnoses in the region in 2007 (Coghlan 
et al., 2009). Reversing the pattern typically seen, 
HIV prevalence in Papua New Guinea is higher 
in rural areas than in urban settings (National 
AIDS Council Secretariat, 2008). The high 
prevalence reported in the country’s rural areas 
is comparable with epidemiological patterns in 
the neighbouring Papua province of Indonesia. 
Among the smaller island nations of the Pacific, 
New Caledonia, Fiji, French Polynesia and Guam 
account for the vast majority of HIV infections 
in the region outside Papua New Guinea 
(Coghlan et al., 2009) (Figure 27).
While most epidemics in the region appear to 
be stable, new infections in Papua New Guinea 
are on the rise. Reported HIV infections are also 
increasing in Fiji, while the rate of new infections 
appears to be declining in New Caledonia 
(Coghlan et al., 2009). In Fiji, the number of new 
HIV case reports in 2003–2006 was nearly 2.5 
times greater than the number reported in 1999–
2002 (Coghlan et al., 2009).
Number of people living with HIV 2008: 59 000  2001: 36 000 
 [51 000–68 000] [29 000–45 000]  
Number of new HIV infections 2008: 3900   2001: 5900
 [2900–5100] [4800–7300]   
Number of children newly infected 2008: <500 2001: <500 
 [<500–<1000] [<200–<500]    
 
Number of AIDS-related deaths 2008: 2000  2001: <1000 
 [1100–3100] [<500–1200]
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A slow, steady increase in new HIV diagnoses is 
also apparent in Australia (Figure 28) and New 
Zealand. Laboratory testing in Australia indicates 
that the rate of recently acquired HIV infections 
rose by roughly 50% between 1998 and 2007 in 
several regions of the country (National Centre 
in HIV Epidemiology and Clinical Research, 
2008), although the number of new HIV diag-
noses nationwide fell modestly between 2006 and 
2008 (from 308 to 281) (National Centre in HIV 
Epidemiology and Clinical Research, 2009). In 
New Zealand, the number of people diagnosed 
through antibody testing in 2008 (184) was the 
highest number ever reported in any single year 
(New Zealand AIDS Epidemiology Group, 2009).
Monitoring of epidemiological trends in the region 
is inhibited by the weakness of HIV surveillance 
systems in many countries. In Papua New Guinea, 
for example, nearly two out of three HIV infections 
reported between 1987 and 2006 have not been 
assigned a mode of transmission (National AIDS 
Council Secretariat, 2008). In particular, existing 
evidence does not permit definitive conclusions 
regarding the impact of regional migration 
on epidemiological trends, nor is it possible to 
determine whether the epidemic in Papua New 
Guinea is affecting neighbouring countries such as 
the Solomon Islands (Coghlan et al., 2009).
Diverse epidemiological patterns
The gender distribution of new infections varies 
considerably between the smaller island nations 
in the region on the one hand and Australia 
and New Zealand on the other. In Papua New 
Guinea, males and females are equally likely 
to become infected, with the risk of infection 
growing among young women (Coghlan et al., 
2009; National AIDS Council Secretariat, 2008). 
By contrast, males account for more than 80% 
of new diagnoses in Australia and New Zealand 
(New Zealand AIDS Epidemiology Group, 2009; 
National Centre in HIV Epidemiology and 
Clinical Research, 2008).
Source: UNAIDS/WHO. 
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The age of those most likely to become infected 
also differs substantially among countries. While 
young women aged between 20 and 24 are most 
likely to be diagnosed with HIV in Papua New 
Guinea (National AIDS Council Secretariat, 2008) 
(Figure 29), the common age group for new HIV 
diagnoses among men who have sex with men in 
New Zealand is 40–49 years (New Zealand AIDS 
Epidemiology Group, 2009). 
Treatment advances in many countries
Although antiretroviral therapy coverage estimates 
are not routinely available throughout the region, a 
number of countries appear to have made impor-
tant strides in expanding access to HIV treatment. 
In Australia, 72% of a national cohort of people 
living with HIV were receiving antiretroviral 
medications in 2006 (Department of Health and 
Ageing, 2008). Among HIV-positive males on 
Source: the Secretariat of the Pacific Community and the Papua New Guinea Department of Health.
French Polynesia 1.1%
New Caledonia 1.2%
All others 0.8%
Guam 0.8%
Fiji 1.1%
Papua New Guinea 95.0%
Proportion of all HIV and AIDS cases in different Pacific island countries and territories,
1984–2007
Figure 27
Source: National Centre in HIV Epidemiology and Clinical Research (2009).
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antiretroviral therapy in Australia in 2006, 85% had 
undetectable viral loads (Department of Health 
and Ageing, 2008).
Late diagnosis of HIV infection reduces the effec-
tiveness of HIV prevention efforts and complicates 
treatment. While it was estimated that approxi-
mately 60 000 people were living with HIV 
in Papua New Guinea in December 2007, the 
cumulative number of people ever diagnosed 
amounted to only 18 484 (National AIDS Council 
Secretariat, 2008). To promote more widespread 
knowledge of HIV serostatus, the Government 
of Papua New Guinea introduced a policy of 
provider-initiated HIV testing and counselling 
in 2007. Between 2007 and 2008, the number 
of people over the age of 15 who received HIV 
testing and counselling in Papua New Guinea 
rose approximately fourfold, from 26 932 to 107 
615 (World Health Organization, United Nations 
Children’s Fund, UNAIDS, 2009).
In Australia, the proportion of AIDS diagnoses 
that occur around the time of HIV diagnosis rose 
from 31% in 1997 to 56% in 2006 (Department of 
Health and Ageing, 2008). Individuals with hetero-
sexually acquired HIV infection or who were born 
in Asia are most likely to be diagnosed late in the 
course of infection in Australia (McDonald et al., 
2007; Körner, 2007).
Key regional dynamics
Modes of transmission vary considerably within 
the region. Heterosexual transmission predomi-
nates in the generalized epidemic of Papua New 
Guinea, while men who have sex with men 
appear to account for roughly half of the national 
epidemics in many other smaller Pacific nations. In 
the larger nations of Australia and New Zealand, 
men who have sex with men is by far the largest 
transmission category for both prevalence and 
incidence. Transmission during injecting drug use 
has made a relatively small contribution to the 
epidemics in Oceania, in part due to the early 
adoption of evidence-informed harm reduction 
programmes in Australia and New Zealand.
Heterosexual transmission
Heterosexual acquisition accounts for nearly 
95% of cumulative HIV diagnoses in Papua New 
Guinea and for almost 88% in Fiji. The proportion 
of heterosexually acquired cases is somewhat lower 
in Melanesia countries other than Papua New 
Guinea (59.4%) and in New Caledonia (36.3%) 
(Coghlan et al., 2009).
The contribution of heterosexual HIV trans-
mission is significantly lower in the region’s 
high-income countries. In Australia, heterosexual 
contact was the transmission mode for 21% 
Source: Papua New Guinea National AIDS Council and Department of Health.
0
500
1000
1500
2000
2500
3000
0−
4
5−
9
10
−1
4
15
−1
9
20
−2
4
25
−2
9
30
−3
4
35
−3
9
40
−4
4
45
−4
9
50
−5
4
55
−5
9
O
ve
r 6
0
Un
kn
ow
n
Male Female Sex not stated
N
um
b
er
 
Age group
HIV infections detected in Papua New Guinea by age, 1987–2006
Figure 29
78
o c E A n I A  |  2 0 0 9  A I D S  E p I D E m I c  u p D A t E
of new HIV diagnoses and for 9% of cases of 
recently acquired HIV infection between 2003 
and 2007 (National Centre in HIV Epidemiology 
and Clinical Research, 2008). One in three new 
HIV diagnoses in New Zealand in 2008 stemmed 
from heterosexual contact (New Zealand AIDS 
Epidemiology Group, 2009).
According to surveys in a number of countries, 
young people exhibit levels of comprehensive 
HIV knowledge that are below the global average 
(Coghlan et al., 2009; UNAIDS, 2008), although 
the vast majority of young people at higher risk 
surveyed knew that condoms could protect against 
sexual HIV transmission (Coghlan et al., 2009). 
However, fewer than half of young people surveyed 
in Papua New Guinea report using a condom 
the last time they had sex with a non-commercial 
partner (Coghlan et al., 2009). Surveys in several 
Pacific nations indicate that a substantial minority of 
young people become sexually active before the age 
of 18, with roughly 40% of young people in Papua 
New Guinea and Vanuatu reporting more than one 
sexual partner (Coghlan et al., 2009). 
Surveys in diverse populations have consistently 
found sexually transmitted infections to be 
endemic in the Pacific islands. Studies in Papua 
New Guinea have typically found a sexually trans-
mitted infection prevalence of 40–60% (Coghlan 
et al., 2009).
The scarcity of recent HIV serosurveys among sex 
workers in the region makes it difficult to quan-
tify the role of sex work in national epidemics. 
Behavioural surveys in Papua New Guinea in 
2006 found that 70% of truck drivers and 61% of 
military personnel reported having paid a woman 
for sex in the previous 12 months (National 
AIDS Council Secretariat, 2008). Also in Papua 
New Guinea, more than two thirds of female sex 
workers surveyed in 2006 reported using condoms 
with their last client, although less than half said 
that they consistently used condoms (National 
AIDS Council Secretariat, 2008). 
Men who have sex with men
Sex between men is the primary driving force of 
several national epidemics in the Pacific region. 
In 2003–2007, men who have sex with men 
made up 68% of newly diagnosed cases of HIV in 
Australia and 86% of newly acquired HIV infec-
tions (National Centre in HIV Epidemiology 
and Research, 2008). In New Zealand, men 
who have sex with men represented 49% of new 
cases diagnosed through antibody testing in 2008 
(New Zealand AIDS Epidemiology Group, 2009). 
Roughly two out of three cumulative diagnoses 
in Guam are among men who have sex with men, 
who also account for the largest share of HIV cases 
in New Caledonia (37%) (Coghlan et al., 2009). 
Consistent with trends in other high-income 
countries, Australia and New Zealand have expe-
rienced an increase in HIV diagnoses in recent 
years among men who have sex with men. In 
New Zealand, for example, annual HIV diagnoses 
among men who have sex with men rose by 89% 
between 2000 and 2006 (New Zealand AIDS 
Epidemiology Group, 2009).
Although existing evidence is not definitive, there 
are signs that the recent growth in HIV diagnoses 
among men who have sex with men in Australia 
and New Zealand stems from increases in sexual 
risk behaviours (Guy et al., 2007). In Australia, 
syphilis rates more than doubled between 2004 
and 2007, with men who have sex with men 
accounting for most new cases (National Centre in 
HIV Epidemiology and Clinical Research, 2008).
Injecting drug use
Transmission during injecting drug use is respon-
sible for a relatively modest share of new HIV 
infections in the region—2% of newly acquired 
infections in Australia between 2003 and 2007 
(National Centre in HIV Epidemiology and 
Clinical Research, 2008) and 1% of new HIV 
diagnoses in New Zealand in 2008 (New Zealand 
AIDS Epidemiology Group, 2009). Somewhat 
higher figures are reported in the smaller Pacific 
island nations, where injecting drug users represent 
11.7% of cumulative HIV case reports in French 
Polynesia and 5.7% in Melanesia (excluding Papua 
New Guinea) (Coghlan et al., 2009). In both 
Fiji and Papua New Guinea, injecting drug users 
account for less than 1% of reported infections 
(Coghlan et al., 2009).
Oceania is home to some of the world’s earliest 
harm reduction programmes. Early in the 
epidemic Australia and New Zealand invested in 
diverse harm reduction services in order to avert 
HIV transmission during drug use. New Zealand 
began offering needle exchange services in 1987, 
and now scores of community pharmacies partici-
pate in the programme (Sheridan et al., 2005).
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Mother-to-child transmission
In the smaller island nations where heterosexual 
contact is a leading mode of HIV transmission, 
the percentage of cumulative HIV diagnoses stem-
ming from perinatal exposure ranges from 2.4% 
in New Caledonia to 7.6% in Papua New Guinea 
(Coghlan et al., 2009). National authorities in 
Papua New Guinea report that rates of mother-to-
child transmission are increasing and that they are 
expected to rise further as the epidemic continues 
to escalate (National AIDS Council Secretariat, 
2008). Papua New Guinea has taken steps to 
expand access to services to prevent mother-to-
child transmission, but prevention coverage in 
antenatal settings was only 2.3% in 2007 (National 
AIDS Council Secretariat, 2008).
In the region’s larger high-income countries, 
with epidemics primarily driven by sex between 
men, rates of mother-to-child transmission are 
extremely low. Only three infants in Australia 
were diagnosed with HIV in 2006–2007 
(National Centre in HIV Epidemiology and 
Clinical Research, 2008), while one child born 
in New Zealand was diagnosed in 2008 (New 
Zealand AIDS Epidemiology Group, 2009).
Prisoners
Little recent evidence is available on HIV preva-
lence in prison settings in Oceania (Dolan et al., 
2007). After studies documented HIV transmission 
in Australian prison settings earlier in the epidemic, 
the country took steps to implement harm 
reduction programmes in prisons (World Health 
Organization, United Nations Office on Drugs 
and Crime, UNAIDS, 2007).
Mobility
In Australia, the per capita rate of HIV diag-
nosis in 2006–2008 was more than eight times 
higher among individuals who immigrated from 
sub-Saharan Africa than among Australian-born 
persons (National Centre in HIV Epidemiology 
and Clinical Research, 2009). Among the relatively 
small percentage of heterosexually acquired cases 
of HIV infection reported in Australia between 
2004 and 2008, 59% were among individuals born 
in sub-Saharan Africa or among individuals with 
sexual partners born in a high-prevalence country 
(National Centre in HIV Epidemiology and 
Clinical Research, 2009).
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Global estimates for adults and children, 2008
People living with HIV  33.4 million [31.1–35.8 million]
New HIV infections in 2008  2.7 million [2.4–3.0 million]
Deaths due to AIDS in 2008  2.0 million [1.7–2.4 million]
The ranges around the estimates in this table define the boundaries within which the actual numbers lie, based 
on the best available information.
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Adults and children estimated to be living 
with HIV, 2008
Total: 33.4 million (31.1–35.8 million) 
Sub-Saharan  
Africa
22.4 million
[20.8–24.1 million]
Latin America
2.0 million
[1.8–2.2 million]
Caribbean
240 000
[220 000–260 000]
North America
1.4 million
[1.2–1.6 million]
Middle East  
and North Africa
310 000
[250 000–380 000]
Western and  
Central Europe
850 000
[710 000–970 000]
Oceania
59 000
[51 000–68 000]
East Asia 
850 000
[700 000–1.0 million]
South and  
South-East Asia
3.8 million
[3.4–4.3 million]
Eastern Europe  
and Central Asia
1.5 million
[1.4–1.7 million]
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Sub-Saharan  
Africa
1.9 million
[1.6–2.2 million]
Latin America
170 000
[150 000–200 000]
Caribbean
20 000
[16 000–24 000]
North America
55 000
[36 000–61 000]
Middle East  
and North Africa
35 000
[24 000–46 000]
Western and  
Central Europe
30 000
[23 000–35 000]
Oceania
3900
[2900–5100]
East Asia 
75 000
[58 000–88 000]
South and  
South-East Asia
280 000
[240 000–320 000]
Eastern Europe  
and Central Asia
110 000 
[100 000–130 000]
Total: 2.7 million (2.4–3.0 million)
Estimated number of adults and children 
newly infected with HIV, 2008 
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Sub-Saharan  
Africa
1.4 million
[1.1–1.7 million]
Latin America
77 000
[66 000–89 000]
Caribbean
12 000
[9300–14 000]
North America
25 000
[20 000–31 000]
Middle East  
and North Africa
20 000
[15 000–25 000]
Western and  
Central Europe
13 000
[10 000–15 000]
Oceania
2000
[1100–3100]
East Asia 
59 000
[46 000–71 000]
South and  
South-East Asia
270 000
[220 000–310 000]
Eastern Europe  
and Central Asia
87 000 
[72 000–110 000]
Estimated adult and child deaths due to AIDS, 
2008 
Total: 2.0 million (1.7–2.4 million)
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